{ "version": "2.2", "instance": { "form20-f.htm": { "nsprefix": "GDTC", "nsuri": "http://w2.cytomed.sg/20251231", "dts": { "inline": { "local": [ "form20-f.htm" ] }, "schema": { "local": [ "gdtc-20251231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2024-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/full_ifrs-cor_2024-03-27.xsd", "https://xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/currency/2024/currency-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "gdtc-20251231_cal.xml" ] }, "definitionLink": { "local": [ "gdtc-20251231_def.xml" ], "remote": [ "https://xbrl.ifrs.org/taxonomy/2024-03-27/full_ifrs/dimensions/dim_full_ifrs_2024-03-27_role-995000.xml" ] }, "labelLink": { "local": [ "gdtc-20251231_lab.xml" ] }, "presentationLink": { "local": [ "gdtc-20251231_pre.xml" ] } }, "keyStandard": 331, "keyCustom": 145, "axisStandard": 32, "axisCustom": 0, "memberStandard": 47, "memberCustom": 54, "hidden": { "total": 383, "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 282, "http://w2.cytomed.sg/20251231": 98, "http://xbrl.sec.gov/dei/2024": 3 }, "contextCount": 466, "entityCount": 1, "segmentCount": 105, "elementCount": 831, "unitCount": 8, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full": 1594, "http://xbrl.sec.gov/dei/2024": 47, "http://xbrl.sec.gov/cyd/2024": 4, "http://xbrl.sec.gov/ecd/2024": 1 }, "report": { "R1": { "role": "http://w2.cytomed.sg/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R2": { "role": "http://w2.cytomed.sg/role/StatementsOfFinancialPositions", "longName": "00000002 - Statement - Consolidated Statements of Financial Positions", "shortName": "Consolidated Statements of Financial Positions", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:TradeAndOtherCurrentReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:TradeAndOtherCurrentReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R3": { "role": "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss", "longName": "00000003 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Loss", "shortName": "Consolidated Statements of Profit or Loss and Other Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:AmortizationOfIntangibleAsset", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R4": { "role": "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "longName": "00000005 - Statement - Consolidated Statements of Changes in Equity", "shortName": "Consolidated Statements of Changes in Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R5": { "role": "http://w2.cytomed.sg/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:LossBeforeIncomeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:LossBeforeIncomeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R6": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc", "longName": "995447 - Disclosure - Insider Trading Policies and Procedures", "shortName": "Insider Trading Policies and Procedures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R8": { "role": "http://w2.cytomed.sg/role/General", "longName": "999014 - Disclosure - GENERAL", "shortName": "GENERAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R9": { "role": "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformation", "longName": "999015 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R10": { "role": "http://w2.cytomed.sg/role/CashAndBankBalances", "longName": "999016 - Disclosure - CASH AND BANK BALANCES", "shortName": "CASH AND BANK BALANCES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R11": { "role": "http://w2.cytomed.sg/role/TradeAndOtherReceivables", "longName": "999017 - Disclosure - TRADE AND OTHER RECEIVABLES", "shortName": "TRADE AND OTHER RECEIVABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R12": { "role": "http://w2.cytomed.sg/role/InvestmentInAssociate", "longName": "999018 - Disclosure - INVESTMENT IN AN ASSOCIATE", "shortName": "INVESTMENT IN AN ASSOCIATE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R13": { "role": "http://w2.cytomed.sg/role/PropertyPlantAndEquipment", "longName": "999019 - Disclosure - PROPERTY, PLANT AND EQUIPMENT", "shortName": "PROPERTY, PLANT AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R14": { "role": "http://w2.cytomed.sg/role/IntangibleAssets", "longName": "999020 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R15": { "role": "http://w2.cytomed.sg/role/FinancialAssetsAtFvoci", "longName": "999021 - Disclosure - FINANCIAL ASSETS, AT FVOCI", "shortName": "FINANCIAL ASSETS, AT FVOCI", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R16": { "role": "http://w2.cytomed.sg/role/TradeAndOtherPayables", "longName": "999022 - Disclosure - TRADE AND OTHER PAYABLES", "shortName": "TRADE AND OTHER PAYABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R17": { "role": "http://w2.cytomed.sg/role/ContractLiabilities", "longName": "999023 - Disclosure - CONTRACT LIABILITIES", "shortName": "CONTRACT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfContractLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfContractLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R18": { "role": "http://w2.cytomed.sg/role/Borrowings", "longName": "999024 - Disclosure - BORROWINGS", "shortName": "BORROWINGS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R19": { "role": "http://w2.cytomed.sg/role/LeaseLiabilities", "longName": "999025 - Disclosure - LEASE LIABILITIES", "shortName": "LEASE LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R20": { "role": "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserve", "longName": "999026 - Disclosure - WARRANT LIABILITIES AND WARRANT RESERVE", "shortName": "WARRANT LIABILITIES AND WARRANT RESERVE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R21": { "role": "http://w2.cytomed.sg/role/ShareCapital", "longName": "999027 - Disclosure - SHARE CAPITAL", "shortName": "SHARE CAPITAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R22": { "role": "http://w2.cytomed.sg/role/CapitalReserve", "longName": "999028 - Disclosure - CAPITAL RESERVE", "shortName": "CAPITAL RESERVE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfCapitalReserveExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfCapitalReserveExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R23": { "role": "http://w2.cytomed.sg/role/Share-basedPaymentReserve", "longName": "999029 - Disclosure - SHARE-BASED PAYMENT RESERVE", "shortName": "SHARE-BASED PAYMENT RESERVE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R24": { "role": "http://w2.cytomed.sg/role/Revenue", "longName": "999030 - Disclosure - REVENUE", "shortName": "REVENUE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R25": { "role": "http://w2.cytomed.sg/role/OtherOperatingIncome", "longName": "999031 - Disclosure - OTHER OPERATING INCOME", "shortName": "OTHER OPERATING INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R26": { "role": "http://w2.cytomed.sg/role/OtherLossesgainsIncludingFairValueChangesOnFinancialInstruments-Net", "longName": "999032 - Disclosure - OTHER (LOSSES)/GAINS INCLUDING FAIR VALUE CHANGES ON FINANCIAL INSTRUMENTS - NET", "shortName": "OTHER (LOSSES)/GAINS INCLUDING FAIR VALUE CHANGES ON FINANCIAL INSTRUMENTS - NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfOtherGainLossNetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfOtherGainLossNetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R27": { "role": "http://w2.cytomed.sg/role/ResearchExpenses", "longName": "999033 - Disclosure - RESEARCH EXPENSES", "shortName": "RESEARCH EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R28": { "role": "http://w2.cytomed.sg/role/EmployeeBenefitsExpenses", "longName": "999034 - Disclosure - EMPLOYEE BENEFITS EXPENSES", "shortName": "EMPLOYEE BENEFITS EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R29": { "role": "http://w2.cytomed.sg/role/FinanceExpenses", "longName": "999035 - Disclosure - FINANCE EXPENSES", "shortName": "FINANCE EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R30": { "role": "http://w2.cytomed.sg/role/OtherExpenses", "longName": "999036 - Disclosure - OTHER EXPENSES", "shortName": "OTHER EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R31": { "role": "http://w2.cytomed.sg/role/IncomeTaxExpense", "longName": "999037 - Disclosure - INCOME TAX EXPENSE", "shortName": "INCOME TAX EXPENSE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R32": { "role": "http://w2.cytomed.sg/role/Commitments", "longName": "999038 - Disclosure - COMMITMENTS", "shortName": "COMMITMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R33": { "role": "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagement", "longName": "999039 - Disclosure - FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R34": { "role": "http://w2.cytomed.sg/role/SegmentInformation", "longName": "999040 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "34", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R35": { "role": "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivities", "longName": "999041 - Disclosure - RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES", "shortName": "RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "35", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R36": { "role": "http://w2.cytomed.sg/role/SignificantRelatedPartyTransactions", "longName": "999042 - Disclosure - SIGNIFICANT RELATED PARTY TRANSACTIONS", "shortName": "SIGNIFICANT RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "36", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R37": { "role": "http://w2.cytomed.sg/role/HoldingCompanyAndRelatedCompanyTransactions", "longName": "999043 - Disclosure - HOLDING COMPANY AND RELATED COMPANY TRANSACTIONS", "shortName": "HOLDING COMPANY AND RELATED COMPANY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "37", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfHoldingCompanyAndRelatedCompanyTransactionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfHoldingCompanyAndRelatedCompanyTransactionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R38": { "role": "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDate", "longName": "999044 - Disclosure - EVENTS OCCURRING AFTER BALANCE SHEET DATE", "shortName": "EVENTS OCCURRING AFTER BALANCE SHEET DATE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "38", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R39": { "role": "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies", "longName": "999045 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION (Policies)", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "39", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfAccountingPolicyForBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfAccountingPolicyForBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R40": { "role": "http://w2.cytomed.sg/role/GeneralTables", "longName": "999046 - Disclosure - GENERAL (Tables)", "shortName": "GENERAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R41": { "role": "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationTables", "longName": "999047 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION (Tables)", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R42": { "role": "http://w2.cytomed.sg/role/CashAndBankBalancesTables", "longName": "999048 - Disclosure - CASH AND BANK BALANCES (Tables)", "shortName": "CASH AND BANK BALANCES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfCashAndCashEquivalentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfCashAndCashEquivalentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R43": { "role": "http://w2.cytomed.sg/role/TradeAndOtherReceivablesTables", "longName": "999049 - Disclosure - TRADE AND OTHER RECEIVABLES (Tables)", "shortName": "TRADE AND OTHER RECEIVABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R44": { "role": "http://w2.cytomed.sg/role/InvestmentInAssociateTables", "longName": "999050 - Disclosure - INVESTMENT IN AN ASSOCIATE (Tables)", "shortName": "INVESTMENT IN AN ASSOCIATE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfInvestmentInAssociateExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfInvestmentInAssociateExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R45": { "role": "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentTables", "longName": "999051 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R46": { "role": "http://w2.cytomed.sg/role/IntangibleAssetsTables", "longName": "999052 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R47": { "role": "http://w2.cytomed.sg/role/FinancialAssetsAtFvociTables", "longName": "999053 - Disclosure - FINANCIAL ASSETS, AT FVOCI (Tables)", "shortName": "FINANCIAL ASSETS, AT FVOCI (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R48": { "role": "http://w2.cytomed.sg/role/TradeAndOtherPayablesTables", "longName": "999054 - Disclosure - TRADE AND OTHER PAYABLES (Tables)", "shortName": "TRADE AND OTHER PAYABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfTradeAndOtherPayablesDetailsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfTradeAndOtherPayablesDetailsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R49": { "role": "http://w2.cytomed.sg/role/ContractLiabilitiesTables", "longName": "999055 - Disclosure - CONTRACT LIABILITIES (Tables)", "shortName": "CONTRACT LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutContractLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureOfContractLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutContractLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureOfContractLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R50": { "role": "http://w2.cytomed.sg/role/BorrowingsTables", "longName": "999056 - Disclosure - BORROWINGS (Tables)", "shortName": "BORROWINGS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R51": { "role": "http://w2.cytomed.sg/role/LeaseLiabilitiesTables", "longName": "999057 - Disclosure - LEASE LIABILITIES (Tables)", "shortName": "LEASE LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R52": { "role": "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveTables", "longName": "999058 - Disclosure - WARRANT LIABILITIES AND WARRANT RESERVE (Tables)", "shortName": "WARRANT LIABILITIES AND WARRANT RESERVE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfWarrantLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfWarrantLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R53": { "role": "http://w2.cytomed.sg/role/ShareCapitalTables", "longName": "999059 - Disclosure - SHARE CAPITAL (Tables)", "shortName": "SHARE CAPITAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R54": { "role": "http://w2.cytomed.sg/role/Share-basedPaymentReserveTables", "longName": "999060 - Disclosure - SHARE-BASED PAYMENT RESERVE (Tables)", "shortName": "SHARE-BASED PAYMENT RESERVE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "54", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R55": { "role": "http://w2.cytomed.sg/role/RevenueTables", "longName": "999061 - Disclosure - REVENUE (Tables)", "shortName": "REVENUE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "55", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R56": { "role": "http://w2.cytomed.sg/role/OtherOperatingIncomeTables", "longName": "999062 - Disclosure - OTHER OPERATING INCOME (Tables)", "shortName": "OTHER OPERATING INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "56", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOtherOperatingIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOtherOperatingIncomeExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R57": { "role": "http://w2.cytomed.sg/role/OtherLossesgainsIncludingFairValueChangesOnFinancialInstruments-NetTables", "longName": "999063 - Disclosure - OTHER (LOSSES)/GAINS INCLUDING FAIR VALUE CHANGES ON FINANCIAL INSTRUMENTS - NET (Tables)", "shortName": "OTHER (LOSSES)/GAINS INCLUDING FAIR VALUE CHANGES ON FINANCIAL INSTRUMENTS - NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "57", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureOfOtherGainLossNetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "GDTC:DisclosureOfOtherGainLossNetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R58": { "role": "http://w2.cytomed.sg/role/ResearchExpensesTables", "longName": "999064 - Disclosure - RESEARCH EXPENSES (Tables)", "shortName": "RESEARCH EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "58", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R59": { "role": "http://w2.cytomed.sg/role/EmployeeBenefitsExpensesTables", "longName": "999065 - Disclosure - EMPLOYEE BENEFITS EXPENSES (Tables)", "shortName": "EMPLOYEE BENEFITS EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "59", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutEmployeeBenefitsExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutEmployeeBenefitsExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R60": { "role": "http://w2.cytomed.sg/role/FinanceExpensesTables", "longName": "999066 - Disclosure - FINANCE EXPENSES (Tables)", "shortName": "FINANCE EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "60", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R61": { "role": "http://w2.cytomed.sg/role/OtherExpensesTables", "longName": "999067 - Disclosure - OTHER EXPENSES (Tables)", "shortName": "OTHER EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "61", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOtherExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOtherExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R62": { "role": "http://w2.cytomed.sg/role/IncomeTaxExpenseTables", "longName": "999068 - Disclosure - INCOME TAX EXPENSE (Tables)", "shortName": "INCOME TAX EXPENSE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "62", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutCurrentIncomeTaxExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutCurrentIncomeTaxExpensesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R63": { "role": "http://w2.cytomed.sg/role/CommitmentsTables", "longName": "999069 - Disclosure - COMMITMENTS (Tables)", "shortName": "COMMITMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "63", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R64": { "role": "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables", "longName": "999070 - Disclosure - FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "64", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R65": { "role": "http://w2.cytomed.sg/role/SegmentInformationTables", "longName": "999071 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "65", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R66": { "role": "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesTables", "longName": "999072 - Disclosure - RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)", "shortName": "RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "66", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DisclosureOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R67": { "role": "http://w2.cytomed.sg/role/SignificantRelatedPartyTransactionsTables", "longName": "999073 - Disclosure - SIGNIFICANT RELATED PARTY TRANSACTIONS (Tables)", "shortName": "SIGNIFICANT RELATED PARTY TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "67", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R68": { "role": "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails", "longName": "999074 - Disclosure - SCHEDULE OF PRINCIPAL ACTIVITIES OF SUBSIDIARIES (Details)", "shortName": "SCHEDULE OF PRINCIPAL ACTIVITIES OF SUBSIDIARIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2025-01-012025-12-31_custom_AdvanceCancerCentrePteLtdMember", "name": "ifrs-full:NameOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:NameOfSubsidiary", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_custom_AdvanceCancerCentrePteLtdMember", "name": "ifrs-full:NameOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:NameOfSubsidiary", "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R69": { "role": "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "longName": "999075 - Disclosure - SCHEDULE OF FINANCIAL INFORMATION OF NON-CONTROLLING INTERESTS (Details)", "shortName": "SCHEDULE OF FINANCIAL INFORMATION OF NON-CONTROLLING INTERESTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_NoncontrollingInterestsMember", "name": "ifrs-full:Revenue", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R70": { "role": "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "longName": "999076 - Disclosure - GENERAL (Details Narrative)", "shortName": "GENERAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:IssuedCapital", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-08-222025-08-22_custom_LongevityBankPteLtdMember", "name": "ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R71": { "role": "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails", "longName": "999077 - Disclosure - SCHEDULE OF PROPERTY PLANT AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)", "shortName": "SCHEDULE OF PROPERTY PLANT AND EQUIPMENT ESTIMATED USEFUL LIVES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_BuildingsMember_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "GDTC:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_BuildingsMember_ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "GDTC:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R72": { "role": "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative", "longName": "999078 - Disclosure - MATERIAL ACCOUNTING POLICY INFORMATION (Details Narrative)", "shortName": "MATERIAL ACCOUNTING POLICY INFORMATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DescriptionOfReasonWhyPresentationCurrencyIsDifferentFromFunctionalCurrency", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "GDTC:DescriptionOfAccountingPolicyForConvenienceTranslationExplanatory", "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:DescriptionOfReasonWhyPresentationCurrencyIsDifferentFromFunctionalCurrency", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "GDTC:DescriptionOfAccountingPolicyForConvenienceTranslationExplanatory", "GDTC:DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R73": { "role": "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails", "longName": "999079 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "shortName": "SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:BalancesWithBanks", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfCashAndCashEquivalentExplanatory", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:BalancesWithBanks", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfCashAndCashEquivalentExplanatory", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R74": { "role": "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative", "longName": "999080 - Disclosure - CASH AND BANK BALANCES (Details Narrative)", "shortName": "CASH AND BANK BALANCES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember", "name": "GDTC:FixedDepositTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_BottomOfRangeMember", "name": "GDTC:FixedDepositTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R75": { "role": "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails", "longName": "999081 - Disclosure - SCHEDULE OF TRADE AND OTHER RECEIVABLES (Details)", "shortName": "SCHEDULE OF TRADE AND OTHER RECEIVABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:OtherReceivables", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfOtherReceivablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfOtherReceivablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R76": { "role": "http://w2.cytomed.sg/role/ScheduleOfInvestmentInAssociateDetails", "longName": "999082 - Disclosure - SCHEDULE OF INVESTMENT IN ASSOCIATE (Details)", "shortName": "SCHEDULE OF INVESTMENT IN ASSOCIATE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfInvestmentInAssociateExplanatory", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R77": { "role": "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative", "longName": "999083 - Disclosure - TRADE AND OTHER RECEIVABLES (Details Narrative)", "shortName": "TRADE AND OTHER RECEIVABLES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:Borrowings", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:BorrowingsMaturity", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R78": { "role": "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails", "longName": "999084 - Disclosure - SCHEDULE OF KEY ASSUMPTIONS OF INVESTMENT IN ASSOCIATE (Details)", "shortName": "SCHEDULE OF KEY ASSUMPTIONS OF INVESTMENT IN ASSOCIATE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "ifrs-full:PercentageOfEntitysRevenue", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R79": { "role": "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "longName": "999085 - Disclosure - SCHEDULE OF FINANCIAL INFORMATION INVESTMENT IN ASSOCIATE (Details)", "shortName": "SCHEDULE OF FINANCIAL INFORMATION INVESTMENT IN ASSOCIATE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_ifrs-full_AssociatesMember", "name": "ifrs-full:CurrentAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfSummarizedFinancialInformationOfMaterialAssociatesExplanatory", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R80": { "role": "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails", "longName": "999086 - Disclosure - SCHEDULE OF RECONCILIATION OF FINANCIAL INFORMATION IN INVESTMENT (Details)", "shortName": "SCHEDULE OF RECONCILIATION OF FINANCIAL INFORMATION IN INVESTMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "ifrs-full:ProportionOfOwnershipInterestInAssociate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31_ifrs-full_AssociatesMember", "name": "GDTC:GroupShareOfNetAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfReconciliationOfFinancialInformationInInvestmentExplanatory", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R81": { "role": "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "longName": "999087 - Disclosure - INVESTMENT IN AN ASSOCIATE (Details Narrative)", "shortName": "INVESTMENT IN AN ASSOCIATE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:ImpairmentLoss", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:ImpairmentLoss", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R82": { "role": "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "longName": "999088 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_ifrs-full_BuildingsMember", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R83": { "role": "http://w2.cytomed.sg/role/ScheduleOfDepreciationExpenseDetails", "longName": "999089 - Disclosure - SCHEDULE OF DEPRECIATION EXPENSE (Details)", "shortName": "SCHEDULE OF DEPRECIATION EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R84": { "role": "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative", "longName": "999090 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details Narrative)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:RightofuseAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:RightofuseAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R85": { "role": "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails", "longName": "999091 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:Goodwill", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:Goodwill", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R86": { "role": "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "longName": "999092 - Disclosure - SCHEDULE OF DETAILED INFORMATION ABOUT INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF DETAILED INFORMATION ABOUT INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_custom_IntellectualPropertiesLicensesMember", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsMaterialToEntityExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R87": { "role": "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "longName": "999093 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE (Details)", "shortName": "SCHEDULE OF AMORTIZATION EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfIntangibleAssetsAmortizationExpensesExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:AmortizationResearchAndDevelopmentExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfIntangibleAssetsAmortizationExpensesExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R88": { "role": "http://w2.cytomed.sg/role/ScheduleOfFinancialAssetsDetails", "longName": "999094 - Disclosure - SCHEDULE OF FINANCIAL ASSETS (Details)", "shortName": "SCHEDULE OF FINANCIAL ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:IncreaseDecreaseInFinancialAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:IncreaseDecreaseInFinancialAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R89": { "role": "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails", "longName": "999095 - Disclosure - SCHEDULE OF TRADE AND OTHER PAYABLES (Details)", "shortName": "SCHEDULE OF TRADE AND OTHER PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfTradeAndOtherPayablesDetailsExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfTradeAndOtherPayablesDetailsExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R90": { "role": "http://w2.cytomed.sg/role/ScheduleOfContractLiabilitiesDetails", "longName": "999096 - Disclosure - SCHEDULE OF CONTRACT LIABILITIES (Details)", "shortName": "SCHEDULE OF CONTRACT LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CurrentContractLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R91": { "role": "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails", "longName": "999097 - Disclosure - SCHEDULE OF UNSATISFIED PERFORMANCE OBLIGATIONS (Details)", "shortName": "SCHEDULE OF UNSATISFIED PERFORMANCE OBLIGATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "AsOf2025-12-31_custom_LaterThanOneYearsAndNotLaterThanFiveYearsMember", "name": "ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionPriceAllocatedToRemainingPerformanceObligationsExplanatory", "GDTC:DisclosureOfContractLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_custom_LaterThanOneYearsAndNotLaterThanFiveYearsMember", "name": "ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionPriceAllocatedToRemainingPerformanceObligationsExplanatory", "GDTC:DisclosureOfContractLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R92": { "role": "http://w2.cytomed.sg/role/ScheduleOfBorrowingsDetails", "longName": "999098 - Disclosure - SCHEDULE OF BORROWINGS (Details)", "shortName": "SCHEDULE OF BORROWINGS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R93": { "role": "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "longName": "999099 - Disclosure - SCHEDULE OF BORROWING OF THE GROUP TO INTEREST RATE CHANGES AND CONTRACTUAL REPAYMENT DATES (Details)", "shortName": "SCHEDULE OF BORROWING OF THE GROUP TO INTEREST RATE CHANGES AND CONTRACTUAL REPAYMENT DATES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:SecuredBankLoansReceived", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutInterestRateChangesAndContractualRepaymentDates", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:SecuredBankLoansReceived", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutInterestRateChangesAndContractualRepaymentDates", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R94": { "role": "http://w2.cytomed.sg/role/ScheduleOfLeaseLiabilitiesDetails", "longName": "999100 - Disclosure - SCHEDULE OF LEASE LIABILITIES (Details)", "shortName": "SCHEDULE OF LEASE LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:LeaseLiabilities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:AdditionOnLeaseLiabilities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R95": { "role": "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails", "longName": "999101 - Disclosure - SCHEDULE OF CONSOLIDATED STATEMENT OF FINANCIAL POSITIONS (Details)", "shortName": "SCHEDULE OF CONSOLIDATED STATEMENT OF FINANCIAL POSITIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CurrentLeaseLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R96": { "role": "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative", "longName": "999102 - Disclosure - BORROWINGS (Details Narrative)", "shortName": "BORROWINGS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:BorrowingsInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_custom_BankLoanMember", "name": "ifrs-full:LoansReceived", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R97": { "role": "http://w2.cytomed.sg/role/LeaseLiabilitiesDetailsNarrative", "longName": "999103 - Disclosure - LEASE LIABILITIES (Details Narrative)", "shortName": "LEASE LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:BorrowingsInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:CashOutflowForLeases", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R98": { "role": "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails", "longName": "999104 - Disclosure - SCHEDULE OF WARRANT LIABILITIES (Details)", "shortName": "SCHEDULE OF WARRANT LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "GDTC:NumberOfWarrantsOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfWarrantLiabilitiesExplanatory", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "GDTC:NumberOfWarrantsOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfWarrantLiabilitiesExplanatory", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R99": { "role": "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails", "longName": "999105 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANTS (Details)", "shortName": "SCHEDULE OF FAIR VALUE OF WARRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_WarrantsMember", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_Level2OfFairValueHierarchyMember_ifrs-full_WarrantsMember", "name": "ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R100": { "role": "http://w2.cytomed.sg/role/ScheduleOfWarrantReserveDetails", "longName": "999106 - Disclosure - SCHEDULE OF WARRANT RESERVE (Details)", "shortName": "SCHEDULE OF WARRANT RESERVE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:WarrantReserve", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureWarrantReserveExplanatory", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": null }, "R101": { "role": "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative", "longName": "999107 - Disclosure - WARRANT LIABILITIES AND WARRANT RESERVE (Details Narrative)", "shortName": "WARRANT LIABILITIES AND WARRANT RESERVE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "AsOf2023-04-13", "name": "GDTC:NoParValuePerShare", "unitRef": "SGDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-04-13", "name": "GDTC:NoParValuePerShare", "unitRef": "SGDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R102": { "role": "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "longName": "999108 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:NumberOfSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NumberOfSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R103": { "role": "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "longName": "999109 - Disclosure - SHARE CAPITAL (Details Narrative)", "shortName": "SHARE CAPITAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:WarrantLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:OfferingExpensesAttributableToIssuanceOfNewShares", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R104": { "role": "http://w2.cytomed.sg/role/ScheduleOfShare-basedPaymentReserveDetails", "longName": "999110 - Disclosure - SCHEDULE OF SHARE-BASED PAYMENT RESERVE (Details)", "shortName": "SCHEDULE OF SHARE-BASED PAYMENT RESERVE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithPartiesOtherThanEmployees", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:CurrencyRealignment", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R105": { "role": "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails", "longName": "999111 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE FROM CONTRACTS WITH CUSTOMERS (Details)", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE FROM CONTRACTS WITH CUSTOMERS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R106": { "role": "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails", "longName": "999112 - Disclosure - SCHEDULE OF OTHER OPERATING INCOME (Details)", "shortName": "SCHEDULE OF OTHER OPERATING INCOME (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:ResearchIncome", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherOperatingIncomeExplanatory", "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:ResearchIncome", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherOperatingIncomeExplanatory", "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R107": { "role": "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "longName": "999113 - Disclosure - SHARE-BASED PAYMENT RESERVE (Details Narrative)", "shortName": "SHARE-BASED PAYMENT RESERVE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "AsOf2025-07-01_ifrs-full_OrdinarySharesMember", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-04-18_custom_TwoThousandTwentyThreeEquityIncentivePlanMember", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R108": { "role": "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails", "longName": "999114 - Disclosure - SCHEDULE OF OTHER (LOSSES)/GAINS - NET (Details)", "shortName": "SCHEDULE OF OTHER (LOSSES)/GAINS - NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "GDTC:FairValueLossGainOnConvertibleLoans", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory", "GDTC:DisclosureOfOtherGainLossNetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "GDTC:FairValueLossGainOnConvertibleLoans", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory", "GDTC:DisclosureOfOtherGainLossNetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R109": { "role": "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails", "longName": "999115 - Disclosure - SCHEDULE OF RESEARCH EXPENSES (Details)", "shortName": "SCHEDULE OF RESEARCH EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:OtherEmployeeExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpensesExplanatory", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:OtherEmployeeExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpensesExplanatory", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R110": { "role": "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails", "longName": "999116 - Disclosure - SCHEDULE OF EMPLOYEE BENEFITS EXPENSES (Details)", "shortName": "SCHEDULE OF EMPLOYEE BENEFITS EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:WagesAndSalaries", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutEmployeeBenefitsExpensesExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:WagesAndSalaries", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutEmployeeBenefitsExpensesExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R111": { "role": "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails", "longName": "999117 - Disclosure - SCHEDULE OF FINANCE EXPENSES (Details)", "shortName": "SCHEDULE OF FINANCE EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:InterestExpenseOnBankLoansAndOverdrafts", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:InterestExpenseOnBankLoansAndOverdrafts", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R112": { "role": "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails", "longName": "999118 - Disclosure - SCHEDULE OF OTHER EXPENSES (Details)", "shortName": "SCHEDULE OF OTHER EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AdvertisingExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherExpensesExplanatory", "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AdvertisingExpense", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherExpensesExplanatory", "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R113": { "role": "http://w2.cytomed.sg/role/ScheduleOfCurrentIncomeTaxExpensesDetails", "longName": "999119 - Disclosure - SCHEDULE OF CURRENT INCOME TAX EXPENSES (Details)", "shortName": "SCHEDULE OF CURRENT INCOME TAX EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentTaxLiabilities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutCurrentIncomeTaxExpensesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentTaxLiabilities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutCurrentIncomeTaxExpensesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R114": { "role": "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails", "longName": "999120 - Disclosure - SCHEDULE OF INCOME TAX EXPENSES (Details)", "shortName": "SCHEDULE OF INCOME TAX EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:TaxExpenseIncomeAtApplicableTaxRate", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutIncomeTaxExpensesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R115": { "role": "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical", "longName": "999121 - Disclosure - SCHEDULE OF INCOME TAX EXPENSES (Details) (Parenthetical)", "shortName": "SCHEDULE OF INCOME TAX EXPENSES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AverageEffectiveTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutIncomeTaxExpensesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AverageEffectiveTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutIncomeTaxExpensesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R116": { "role": "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails", "longName": "999122 - Disclosure - SCHEDULE OF UNUTILIZED TAX LOSSES (Details)", "shortName": "SCHEDULE OF UNUTILIZED TAX LOSSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfUnutilizedTaxLossesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfUnutilizedTaxLossesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R117": { "role": "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetailsParenthetical", "longName": "999123 - Disclosure - SCHEDULE OF UNUTILIZED TAX LOSSES (Details) (Parenthetical)", "shortName": "SCHEDULE OF UNUTILIZED TAX LOSSES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "GDTC:DisclosureOfUnutilizedTaxLossesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "GDTC:DisclosureOfUnutilizedTaxLossesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R118": { "role": "http://w2.cytomed.sg/role/ScheduleOfOperatingLeaseCommitmentsDetails", "longName": "999124 - Disclosure - SCHEDULE OF OPERATING LEASE COMMITMENTS (Details)", "shortName": "SCHEDULE OF OPERATING LEASE COMMITMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "GDTC:OperatingLeaseCommitments", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseCommitmentsExplanatory", "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "GDTC:OperatingLeaseCommitments", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseCommitmentsExplanatory", "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R119": { "role": "http://w2.cytomed.sg/role/ScheduleOfCapitalCommitmentsDetails", "longName": "999125 - Disclosure - SCHEDULE OF CAPITAL COMMITMENTS (Details)", "shortName": "SCHEDULE OF CAPITAL COMMITMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "ifrs-full:PurchaseOfInvestmentProperty", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutCapitalCommitmentsExplanatory", "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "ifrs-full:PurchaseOfInvestmentProperty", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutCapitalCommitmentsExplanatory", "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R120": { "role": "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "longName": "999126 - Disclosure - SCHEDULE OF FUTURE MINIMUM PAYMENTS UNDER NON-CANCELLABLE (Details)", "shortName": "SCHEDULE OF FUTURE MINIMUM PAYMENTS UNDER NON-CANCELLABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:LeaseLiabilities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_custom_LicencingAgreementMember", "name": "ifrs-full:LeaseLiabilities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "ifrs-full:DisclosureOfCommitmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R121": { "role": "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "longName": "999127 - Disclosure - SCHEDULE OF FINANCIAL INSTRUMENTS (Details)", "shortName": "SCHEDULE OF FINANCIAL INSTRUMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:OtherReceivables", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfOtherReceivablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:FinancialAssetsAtAmortisedCost", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R122": { "role": "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "longName": "999128 - Disclosure - SCHEDULE OF CURRENCY EXPOSURE BASED ON THE INFORMATION (Details)", "shortName": "SCHEDULE OF CURRENCY EXPOSURE BASED ON THE INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfCashAndCashEquivalentExplanatory", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_currency_SGD", "name": "ifrs-full:FinancialAssets", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfCreditRiskExposureExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R123": { "role": "http://w2.cytomed.sg/role/IncomeTaxExpenseDetailsNarrative", "longName": "999129 - Disclosure - INCOME TAX EXPENSE (Details Narrative)", "shortName": "INCOME TAX EXPENSE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "GDTC:UnusedTaxLossesForDeferredTaxAsset", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "GDTC:UnusedTaxLossesForDeferredTaxAsset", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R124": { "role": "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails", "longName": "999130 - Disclosure - SCHEDULE OF NET FINANCIAL LIABILITY ASSET CURRENCY RISK (Details)", "shortName": "SCHEDULE OF NET FINANCIAL LIABILITY ASSET CURRENCY RISK (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "From2025-01-012025-12-31_custom_USDAgainstSGDMember_custom_StrengthenedMember", "name": "ifrs-full:IncreaseDecreaseThroughLossOfControlOfSubsidiaryDeferredTaxLiabilityAsset", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfNetFinancialLiabilityAssetCurrencyRiskExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_custom_USDAgainstSGDMember_custom_StrengthenedMember", "name": "ifrs-full:IncreaseDecreaseThroughLossOfControlOfSubsidiaryDeferredTaxLiabilityAsset", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfNetFinancialLiabilityAssetCurrencyRiskExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R125": { "role": "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "longName": "999131 - Disclosure - SCHEDULE OF REMAINING CONTRACTUAL MATURITIES (Details)", "shortName": "SCHEDULE OF REMAINING CONTRACTUAL MATURITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "125", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:TradeAndOtherPayables", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfTradeAndOtherPayablesDetailsExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember", "name": "ifrs-full:TradeAndOtherPayables", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R126": { "role": "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "longName": "999132 - Disclosure - SCHEDULE OF EACH CLASS OF FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE (Details)", "shortName": "SCHEDULE OF EACH CLASS OF FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "126", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "GDTC:UnquotedEquityInstruments", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember", "name": "ifrs-full:CurrentWarrantLiability", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R127": { "role": "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "longName": "999133 - Disclosure - SCHEDULE OF CAPITAL BASED ON DEBT-TO-EQUITY RATIO (Details)", "shortName": "SCHEDULE OF CAPITAL BASED ON DEBT-TO-EQUITY RATIO (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "127", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:Borrowings", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "GDTC:DebttoequityRatio", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R128": { "role": "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails", "longName": "999134 - Disclosure - SCHEDULE OF GEOGRAPHICAL INFORMATION IN NON-CURRENT ASSETS (Details)", "shortName": "SCHEDULE OF GEOGRAPHICAL INFORMATION IN NON-CURRENT ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "128", "firstAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-12-31", "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R129": { "role": "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "longName": "999135 - Disclosure - SCHEDULE OF BUSINESS SEGMENT (Details)", "shortName": "SCHEDULE OF BUSINESS SEGMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "129", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:Revenue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_custom_ImmuneCellTherapyMember", "name": "ifrs-full:ComprehensiveIncome", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R130": { "role": "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "longName": "999136 - Disclosure - FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT (Details Narrative)", "shortName": "FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "130", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:BankDebtInstrumentsHeld", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "ifrs-full:BankDebtInstrumentsHeld", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R131": { "role": "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails", "longName": "999137 - Disclosure - SCHEDULE OF RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Details)", "shortName": "SCHEDULE OF RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "131", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_BankLoanMember", "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R132": { "role": "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical", "longName": "999138 - Disclosure - SCHEDULE OF RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Details) (Parenthetical)", "shortName": "SCHEDULE OF RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "132", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory", "GDTC:DisclosureOfOtherGainLossNetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-12-31_ifrs-full_LeaseLiabilitiesMember82249437", "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "i", "td", "tr", "table", "GDTC:DisclosureOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R133": { "role": "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "longName": "999139 - Disclosure - RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Details Narrative)", "shortName": "RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "133", "firstAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "GDTC:IncreaseDecreaseThroughWarrantReserveCapitalized", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "GDTC:DisclosureWarrantReserveExplanatory", "GDTC:DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31_ifrs-full_WarrantReserveMember", "name": "GDTC:IncreaseDecreaseThroughWarrantReserveCapitalized", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } }, "R134": { "role": "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails", "longName": "999140 - Disclosure - SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)", "shortName": "SCHEDULE OF RELATED PARTY TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "134", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R135": { "role": "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails", "longName": "999141 - Disclosure - SCHEDULE OF REMUNERATION OF DIRECTORS AND KEY MANAGEMENT PERSONNEL (Details)", "shortName": "SCHEDULE OF REMUNERATION OF DIRECTORS AND KEY MANAGEMENT PERSONNEL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "135", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true, "unique": true } }, "R136": { "role": "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "longName": "999142 - Disclosure - EVENTS OCCURRING AFTER BALANCE SHEET DATE (Details Narrative)", "shortName": "EVENTS OCCURRING AFTER BALANCE SHEET DATE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "136", "firstAnchor": { "contextRef": "From2025-01-01to2025-12-31", "name": "ifrs-full:ProceedsFromIssueOfOrdinaryShares", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2026-01-142026-01-14_ifrs-full_OrdinarySharesMember_custom_NonadjustingEventMember", "name": "ifrs-full:ProceedsFromIssueOfOrdinaryShares", "unitRef": "SGD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "form20-f.htm", "unique": true } } }, "tag": { "GDTC_ATMSalesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ATMSalesAgreementMember", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ATM Sales Agreement [Member]", "documentation": "ATM Sales Agreement [Member]" } } }, "auth_ref": [] }, "GDTC_AccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AccruedExpenses", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued operating expenses", "documentation": "Accrued expenses." } } }, "auth_ref": [] }, "GDTC_AccumulatedDepreciationMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AccumulatedDepreciationMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation [member]", "documentation": "Accumulated depreciation [member]" } } }, "auth_ref": [] }, "GDTC_AccumulatedNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AccumulatedNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated NCI", "documentation": "Accumulated noncontrolling interests." } } }, "auth_ref": [] }, "GDTC_AdditionOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AdditionOnLeaseLiabilities", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Addition in the year", "documentation": "Addition on lease liabilities." } } }, "auth_ref": [] }, "GDTC_AdditionToUnabsorbedCapitalAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AdditionToUnabsorbedCapitalAllowance", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Addition", "documentation": "Addition to unabsorbed capital allowance.", "label": "AdditionToUnabsorbedCapitalAllowance" } } }, "auth_ref": [] }, "GDTC_AdditionToUnusedTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AdditionToUnusedTaxLosses", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Addition", "documentation": "Addition to unused tax losses.", "label": "AdditionToUnusedTaxLosses" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r337" ] }, "ifrs-full_AdditionalPaidinCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdditionalPaidinCapitalMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital [member]" } }, "en": { "role": { "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r392" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency realignment", "label": "Additions other than through business combinations, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r103" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Addition" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r53" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AddressTypeDomain", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r343" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r343" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r343" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r343" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r93" ] }, "ifrs-full_AdjustmentsForAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForAmortisationExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets" } }, "en": { "role": { "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade and other receivables", "label": "Adjustments for decrease (increase) in trade and other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation of property, plant and equipment (per above)" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } } }, "auth_ref": [ "r411" ] }, "ifrs-full_AdjustmentsForDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForDepreciationExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation of property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r412" ] }, "GDTC_AdjustmentsForFairValueLossgainOnConvertibleLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AdjustmentsForFairValueLossgainOnConvertibleLoans", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Fair value losses on convertible loans", "documentation": "Adjustments for fair value loss gain on convertible loans." } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "label": "Disposal", "verboseLabel": "Gain on disposal of profit or loss" } }, "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInContractLiabilities", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Contract liabilities", "label": "Adjustments for increase (decrease) in contract liabilities" } }, "en": { "role": { "documentation": "Adjustments for the increase (decrease) in contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Contract liabilities; Profit (loss)]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade and other payables", "label": "Adjustments for increase (decrease) in trade accounts payable" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for:" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based payment", "label": "Adjustments for share-based payments" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r411" ] }, "GDTC_AdjustmentsForUnrealizedCurrencyTranslationGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AdjustmentsForUnrealizedCurrencyTranslationGainsLosses", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized currency translation (gains)/losses", "documentation": "Adjustments for unrealized currency translation gains losses", "label": "AdjustmentsForUnrealizedCurrencyTranslationGainsLosses" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Operating cash flows before movements in working capital", "label": "Adjustments to reconcile profit (loss) other than changes in working capital" } }, "en": { "role": { "documentation": "Adjustments, other than changes in working capital, to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r412" ] }, "GDTC_AdvanceCancerCentrePteLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AdvanceCancerCentrePteLtdMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Advance Cancer Centre Pte Ltd [member]", "documentation": "Advance Cancer Centre Pte Ltd [member]" } } }, "auth_ref": [] }, "ifrs-full_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AdvertisingExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising" } }, "en": { "role": { "documentation": "The amount of expense arising from advertising." } } }, "auth_ref": [ "r393" ] }, "GDTC_AggregateOfferingPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AggregateOfferingPrice", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate offering price", "documentation": "Aggregate offering price." } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r304", "r315", "r329", "r355" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r307", "r318", "r332", "r358" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r343" ] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2024", "localname": "AllCurrenciesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r350" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r308", "r319", "r333", "r350", "r359", "r363", "r371" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r369" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AmortisationExpense", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Amortization expense" } }, "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Amortization charge", "verboseLabel": "Total" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r105" ] }, "GDTC_AmortizationOfIntangibleAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AmortizationOfIntangibleAsset", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of intangible assets", "documentation": "Amortization of intangible asset.", "label": "AmortizationOfIntangibleAsset" } } }, "auth_ref": [] }, "GDTC_AmortizationOfIntangibleAssetResearchAndDevelopmentExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AmortizationOfIntangibleAssetResearchAndDevelopmentExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets (Note 8)", "documentation": "Amortization of intangible asset research and development expenses." } } }, "auth_ref": [] }, "GDTC_AmortizationResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AmortizationResearchAndDevelopmentExpense", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "\u201cResearch expenses\u201d (Note 21)", "documentation": "Amortization research and development expense.", "label": "AmortizationResearchAndDevelopmentExpense" } } }, "auth_ref": [] }, "ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "label": "Amount incurred by entity for provision of key management personnel services provided by separate management entity" } }, "en": { "role": { "documentation": "The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [domain]]" } } }, "auth_ref": [ "r74" ] }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AmountsReceivableRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivable from associate" } }, "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r72", "r77" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r311" ] }, "GDTC_AnnualListingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AnnualListingFee", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Annual listing fee", "documentation": "Annual Listing Fee." } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "periodEndLabel": "Total assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r18", "r155", "r156", "r157", "r214", "r217" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "ifrs-full_AssociatesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AssociatesMember", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Total for all associates [member]" } }, "en": { "role": { "documentation": "This member stands for the entities over which the investor has significant influence." } } }, "auth_ref": [ "r75", "r86", "r90", "r154" ] }, "GDTC_AtAPointInTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AtAPointInTimeMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "label": "At A Point In Time [member]", "documentation": "At A Point In Time [member]" } } }, "auth_ref": [] }, "GDTC_AtTheMarketMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "AtTheMarketMember", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "At-the-market [member]", "documentation": "At-the-market [member]" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r311" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r288", "r290", "r311" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r288", "r290", "r311" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r288", "r290", "r311" ] }, "ifrs-full_AverageEffectiveTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AverageEffectiveTaxRate", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Tax rate" } }, "en": { "role": { "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]" } } }, "auth_ref": [ "r47" ] }, "ifrs-full_AverageForeignExchangeRate": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "AverageForeignExchangeRate", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Currency risk rate" } }, "en": { "role": { "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies." } } }, "auth_ref": [ "r393" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r366" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r367" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r362" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r362" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r362" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r362" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r362" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r362" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r365" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r364" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r363" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r363" ] }, "ifrs-full_BalancesWithBanks": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BalancesWithBanks", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "GDTC_CashAndCashEquivalentsBeforeFixedDepositMaturityAdjustment", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash at banks" } }, "en": { "role": { "documentation": "The amount of cash balances held at banks." } } }, "auth_ref": [ "r413" ] }, "GDTC_BankBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "BankBorrowingsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Bank borrowings [member]", "documentation": "Bank borrowings [member]" } } }, "auth_ref": [] }, "ifrs-full_BankDebtInstrumentsHeld": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BankDebtInstrumentsHeld", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bank loan" } }, "en": { "role": { "documentation": "The amount of debt instruments, including instruments called debt securities, held by the entity that were issued by a bank. [Refer: Debt instruments held]" } } }, "auth_ref": [ "r393" ] }, "GDTC_BankLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "BankLoanMember", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "label": "Bank loan [member]", "documentation": "Bank loan [member]" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Basic" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r91", "r92" ] }, "ifrs-full_BasicEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BasicEarningsPerShareAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss per share attributable to equity holders of the Company:" } } }, "auth_ref": [] }, "GDTC_BestTwoPointZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "BestTwoPointZeroMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "BeST 2.0 [member]", "documentation": "BeST 2.0\t[member]" } } }, "auth_ref": [] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Borrowings", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingsDetails", "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan amount", "verboseLabel": "Total", "negatedLabel": "Borrowings", "terseLabel": "Borrowings (excluding lease liabilities)" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r395" ] }, "GDTC_BorrowingsCurrencyRealignment": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "BorrowingsCurrencyRealignment", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Currency realignment, Amount", "documentation": "Borrowings currency realignment." } } }, "auth_ref": [] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative", "http://w2.cytomed.sg/role/LeaseLiabilitiesDetailsNarrative", "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan interest rate", "verboseLabel": "Fixed interest rate", "terseLabel": "Depreciation lease liability" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_BorrowingsMaturity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BorrowingsMaturity", "presentation": [ "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan maturity" } }, "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r126", "r159", "r180", "r185", "r258", "r259", "r414" ] }, "ifrs-full_BuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "BuildingsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Buildings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r402" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "BusinessContactMember", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r290", "r311" ] }, "GDTC_CBUServiceAndRelatedTherapyMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CBUServiceAndRelatedTherapyMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "label": "CBU service & related therapy [member]", "documentation": "CBU service & related therapy [member]" } } }, "auth_ref": [] }, "ifrs-full_CapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CapitalReserve", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Capital reserve" } }, "en": { "role": { "documentation": "A component of equity representing the capital reserves." } } }, "auth_ref": [ "r395" ] }, "ifrs-full_CapitalReserveMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CapitalReserveMember", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Capital reserve [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing capital reserves." } } }, "auth_ref": [ "r392" ] }, "GDTC_CapitalizationOfNewLeasesDuringYear": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CapitalizationOfNewLeasesDuringYear", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalization of new lease", "documentation": "Capitalization of new leases during year.", "label": "CapitalizationOfNewLeasesDuringYear" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r52", "r58", "r102", "r107", "r113", "r114", "r115", "r116", "r117", "r187", "r193", "r194" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r58", "r107", "r113", "r115", "r116", "r187", "r193", "r194" ] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Cash", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Cash and bank balances", "verboseLabel": "Cash consideration" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r413" ] }, "ifrs-full_CashAdvancesAndLoansMadeToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashAdvancesAndLoansMadeToRelatedParties", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loan to a related party - net", "label": "Cash advances and loans made to related parties" } }, "en": { "role": { "documentation": "The cash outflow for loans and advances made to related parties. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r408" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails", "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of year", "periodEndLabel": "Cash and cash equivalents at end of year", "totalLabel": "Cash and cash equivalents on consolidated statements of cash flows", "verboseLabel": "Cash and bank balances", "label": "Cash and cash equivalents [Default Label]" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r13", "r127", "r149" ] }, "GDTC_CashAndCashEquivalentsBeforeFixedDepositMaturityAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CashAndCashEquivalentsBeforeFixedDepositMaturityAdjustment", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Cash and cash equivalents", "label": "Cash and cash equivalents", "documentation": "Cash and cash equivalents before fixed deposit maturity adjustment." } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Fixed deposits with maturities over 3 months" } }, "en": { "role": { "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments." } } }, "auth_ref": [ "r408" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash generated from/(used in) financing activities", "label": "Cash flows generated from financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations." } } }, "auth_ref": [ "r118", "r129" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financing activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in)/generated from investing activities", "label": "Cash flows used in investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations." } } }, "auth_ref": [ "r118", "r129" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investing activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Cash flows generated from operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue]" } } }, "auth_ref": [ "r118", "r129" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperations", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash used in operations", "label": "Cash flows from (used in) operations" } }, "en": { "role": { "documentation": "The cash from (used in) the entity's operations." } } }, "auth_ref": [ "r251", "r254" ] }, "ifrs-full_CashOnHand": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashOnHand", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "GDTC_CashAndCashEquivalentsBeforeFixedDepositMaturityAdjustment", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash on hand" } }, "en": { "role": { "documentation": "The amount of cash held by the entity. This does not include demand deposits." } } }, "auth_ref": [ "r413" ] }, "ifrs-full_CashOutflowForLeases": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashOutflowForLeases", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/LeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash flow for leases" } }, "en": { "role": { "documentation": "The cash outflow for leases." } } }, "auth_ref": [ "r171" ] }, "ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CashRepaymentsOfAdvancesAndLoansFromRelatedParties", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payment of third party loan", "label": "Cash repayments of advances and loans from related parties" } }, "en": { "role": { "documentation": "The cash outflow for repayments of advances and loans from related parties. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CategoriesOfFinancialLiabilitiesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Categories of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r205" ] }, "ifrs-full_CategoriesOfFinancialLiabilitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CategoriesOfFinancialLiabilitiesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r205" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails", "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_CategoriesOfRelatedPartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CategoriesOfRelatedPartiesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails", "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r76" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r341" ] }, "ifrs-full_ChangesInEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ChangesInEquity", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Total transactions with owners of the Company" } }, "en": { "role": { "documentation": "The increase (decrease) in equity. [Refer: Equity]" } } }, "auth_ref": [ "r4" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfFinancialAssetsAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r182", "r199", "r200", "r227", "r228" ] }, "ifrs-full_ClassesOfFinancialAssetsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfFinancialAssetsDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r182", "r199", "r200", "r227", "r228" ] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r193", "r195", "r196", "r197" ] }, "ifrs-full_ClassesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfFinancialInstrumentsDomain", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r193", "r195", "r196", "r197" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r199", "r200", "r227", "r228" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r199", "r200", "r227", "r228" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r108" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used." } } }, "auth_ref": [ "r108" ] }, "ifrs-full_ClassesOfLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfLiabilitiesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Classes of liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_ClassesOfLiabilitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfLiabilitiesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "auth_ref": [ "r158" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative", "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentDomain", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative", "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_ClassesOfShareCapitalDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ClassesOfShareCapitalDomain", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r27" ] }, "GDTC_ClinicalTrialExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ClinicalTrialExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Clinical trial expenses", "documentation": "Clinical trial expenses." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r342" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r342" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r347" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r346" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r348" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r345" ] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_ComponentsOfEquityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComponentsOfEquityDomain", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss for the year", "verboseLabel": "Total", "label": "Total comprehensive loss for the year", "terseLabel": "Operating results" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r1", "r30", "r132", "r134", "r147", "r257" ] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Total comprehensive loss attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-controlling interests", "totalLabel": "Total comprehensive loss allocated to NCI", "label": "Comprehensive income, attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r1", "r32" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity holders of the Company", "label": "Comprehensive income, attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r1", "r33" ] }, "ifrs-full_ComputerSoftware": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComputerSoftware", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "ifrs-full_IntangibleAssetsAndGoodwill", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Computer software licenses (Note (b))" } }, "en": { "role": { "documentation": "The amount of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r241" ] }, "GDTC_ComputerSoftwareLicensesMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ComputerSoftwareLicensesMember", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Computer software licenses [member]", "documentation": "Computer software licenses [member]" } } }, "auth_ref": [] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Computer software [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r241" ] }, "GDTC_ConsumablesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ConsumablesExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Consumables expenses", "documentation": "Consumables expense." } } }, "auth_ref": [] }, "dei_ContactPersonnelEmailAddress": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContactPersonnelEmailAddress", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Email Address", "documentation": "Email address of contact personnel." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ContactPersonnelName", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "ifrs-full_ContractDurationAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ContractDurationAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails" ], "lang": { "en-us": { "role": { "label": "Contract duration [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_ContractDurationDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ContractDurationDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all durations of contracts with customers. It also represents the standard value for the 'Contract duration' axis if no other member is used." } } }, "auth_ref": [ "r262" ] }, "GDTC_ConvertibleLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ConvertibleLoanMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible loan [member]", "documentation": "Convertible loan [member]" } } }, "auth_ref": [] }, "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRights": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRights", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "ifrs-full_IntangibleAssetsAndGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intellectual properties licenses (Note (a))" } }, "en": { "role": { "documentation": "The amount of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r207" ] }, "ifrs-full_CounterpartiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CounterpartiesDomain", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r207" ] }, "ifrs-full_CountryOfIncorporation": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CountryOfIncorporation", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Country of business / incorporation" } }, "en": { "role": { "documentation": "The country in which the entity is incorporated." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_CountryOfIncorporationOrResidenceOfAssociate": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CountryOfIncorporationOrResidenceOfAssociate", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Country of business / incorporation", "label": "Country of incorporation of associate" } }, "en": { "role": { "documentation": "The country in which an associate of the entity is incorporated. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r84", "r88", "r141" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CurrencyAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "auth_ref": [] }, "GDTC_CurrencyExposureOfFinancialAssetsNetOfThoseDenominatedInCompanysFunctionalCurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CurrencyExposureOfFinancialAssetsNetOfThoseDenominatedInCompanysFunctionalCurrency", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Currency exposure of financial assets, net of those denominated in the Company\u2019s functional currency", "documentation": "Currency exposure of financial assets net of those denominated in companys functional currency." } } }, "auth_ref": [] }, "ifrs-full_CurrencyInWhichInformationIsDisplayedAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrencyInWhichInformationIsDisplayedAxis", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Currency in which information is displayed [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r71" ] }, "GDTC_CurrencyRealignment": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CurrencyRealignment", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShare-basedPaymentReserveDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency realignment", "documentation": "Currency realignment.", "label": "CurrencyRealignment" } } }, "auth_ref": [] }, "GDTC_CurrencyRealignmentNumberOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CurrencyRealignmentNumberOfWarrants", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Currency realignment, Number of Warrants", "documentation": "Currency realignment number of warrants." } } }, "auth_ref": [] }, "GDTC_CurrencyRealignmentOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CurrencyRealignmentOnLeaseLiabilities", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency realignment", "documentation": "Currency realignment on lease liabilities.", "label": "CurrencyRealignmentOnLeaseLiabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentAdvancesToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentAdvancesToSuppliers", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid consumables" } }, "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "verboseLabel": "Current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r21", "r143", "r257" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "ifrs-full_CurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentContractLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfContractLiabilitiesDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Contract liabilities" } }, "en": { "role": { "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r160" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 1.0 }, "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "verboseLabel": "Current" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r169" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "verboseLabel": "Current liabilities", "negatedLabel": "Current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r22", "r145", "r257" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Prepayments" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Goods and services tax receivable" } }, "en": { "role": { "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } } }, "auth_ref": [ "r396" ] }, "ifrs-full_CurrentTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentTaxLiabilities", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrentIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Current tax liability" } }, "en": { "role": { "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r15" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r232", "r233" ] }, "ifrs-full_CurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CurrentWarrantLiability", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrant liabilities", "verboseLabel": "Warrant liabilities", "label": "Current warrant liability" } }, "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r395" ] }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "CustomerrelatedIntangibleAssetsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Customer-related intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } } }, "auth_ref": [ "r407" ] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r298", "r381" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r298", "r381" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r300", "r383" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r300", "r383" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r293", "r376" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r294", "r377" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r294", "r377" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r292", "r375" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r295", "r378" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r297", "r380" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r297", "r380" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r298", "r381" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r299", "r382" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r296", "r379" ] }, "GDTC_CytoMedTherapeuticsMalaysiaSdnBhdMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "CytoMedTherapeuticsMalaysiaSdnBhdMember", "presentation": [ "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "CytoMed Therapeutics (Malaysia) Sdn Bhd [member]", "documentation": "CytoMed Therapeutics (Malaysia) Sdn Bhd [member]" } } }, "auth_ref": [] }, "GDTC_DebtToEquityRatioMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DebtToEquityRatioMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails" ], "lang": { "en-us": { "role": { "label": "Debt to equity ratio [member]", "documentation": "Debt to equity ratio [member]" } } }, "auth_ref": [] }, "GDTC_DebttoequityRatio": { "xbrltype": "decimalItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DebttoequityRatio", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails" ], "lang": { "en-us": { "role": { "label": "Debt-to-equity ratio", "documentation": "Debt-to-equity ratio." } } }, "auth_ref": [] }, "ifrs-full_DeferredIncomeOtherThanContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DeferredIncomeOtherThanContractLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred income" } }, "en": { "role": { "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, other than contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r395", "r398" ] }, "ifrs-full_DeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DeferredTaxExpenseIncome", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecorded approximate deferred tax benefits @ 17%" } }, "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r49" ] }, "ifrs-full_DefinedBenefitPlansAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DefinedBenefitPlansAxis", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined benefit plans [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r63" ] }, "ifrs-full_DefinedBenefitPlansDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DefinedBenefitPlansDomain", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used." } } }, "auth_ref": [ "r63" ] }, "GDTC_DefinedContributionPlansMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DefinedContributionPlansMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Defined contribution plans [member]", "documentation": "Defined contribution plans [member]" } } }, "auth_ref": [] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDepreciationExpenseDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation of property, plant and equipment", "totalLabel": "Total", "label": "Depreciation, property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r56", "r61" ] }, "GDTC_DepreciationResearchAndDevelopmentExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DepreciationResearchAndDevelopmentExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation of property, plant and equipment (Note 7)", "documentation": "Depreciation research and development expenses." } } }, "auth_ref": [] }, "GDTC_DepreciationUnderResearchExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DepreciationUnderResearchExpenses", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "\u201cResearch expenses\u201d (Note 21)", "documentation": "Depreciation under research expenses." } } }, "auth_ref": [] }, "GDTC_DescriptionOfAccountingPolicyForAdoptionOfNewAndAmendedStandardsAndInterpretationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfAccountingPolicyForAdoptionOfNewAndAmendedStandardsAndInterpretationsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "Adoption of new and revised standards", "documentation": "Description of accounting policy for adoption of new and amended standards and interpretations explanatory." } } }, "auth_ref": [] }, "GDTC_DescriptionOfAccountingPolicyForBasicOfAccountingExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfAccountingPolicyForBasicOfAccountingExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "BASIS OF ACCOUNTING", "documentation": "Description of accounting policy for basis of accounting explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForBorrowingCostsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "BORROWINGS", "label": "Description of accounting policy for borrowing costs [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for interest and other costs that the entity incurs in connection with the borrowing of funds." } } }, "auth_ref": [ "r394" ] }, "GDTC_DescriptionOfAccountingPolicyForConvenienceTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfAccountingPolicyForConvenienceTranslationExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "CONVENIENCE TRANSLATION", "documentation": "Description of accounting policy for convenience translation explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "FINANCIAL ASSETS" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "FINANCIAL LIABILITIES AND EQUITY INSTRUMENTS" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "FOREIGN CURRENCY TRANSACTIONS" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "GOVERNMENT GRANTS" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r67" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "IMPAIRMENT OF NON-FINANCIAL ASSETS" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "INCOME TAX" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "INTANGIBLE ASSETS", "label": "Description of accounting policy for intangible assets other than goodwill [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForInvestmentInAssociates", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "INVESTMENT IN AN ASSOCIATE", "label": "Description of accounting policy for investment in associates [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for investments in associates. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "SHARE CAPITAL", "label": "Description of accounting policy for issued capital [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "LEASES" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } } }, "auth_ref": [ "r394" ] }, "GDTC_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedButNotYetEffectiveExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsIssuedButNotYetEffectiveExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "New and revised standards in issued but not yet effective", "documentation": "Description of accounting policy for new standards amendments and interpretations issued but not yet effective explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "PROPERTY, PLANT AND EQUIPMENT", "label": "Description of accounting policy for property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "PROVISIONS" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "REVENUE RECOGNITION" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r394" ] }, "GDTC_DescriptionOfAccountingPolicyForRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfAccountingPolicyForRelatedPartiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "RELATED PARTIES", "documentation": "Description of accounting policy for related parties explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "RESEARCH EXPENSES", "label": "Description of accounting policy for research and development expense [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r394" ] }, "GDTC_DescriptionOfAccountingPolicyForReservesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfAccountingPolicyForReservesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "RESERVES", "documentation": "Description of accounting policy for reserves explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "SEGMENT REPORTING" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for segment reporting." } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "TRADE AND OTHER PAYABLES", "label": "Description of accounting policy for trade and other payables [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "CASH AND BANK BALANCES", "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r128" ] }, "GDTC_DescriptionOfDilutedEquityInterestPercentage": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfDilutedEquityInterestPercentage", "presentation": [ "http://w2.cytomed.sg/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of diluted equity interest percentage", "documentation": "Description of diluted equity interest percentage." } } }, "auth_ref": [] }, "GDTC_DescriptionOfExpectedTerm": { "xbrltype": "durationItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DescriptionOfExpectedTerm", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Expected term (years)", "documentation": "Expected term (years)." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r186" ] }, "ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Principal activities" } }, "en": { "role": { "documentation": "The description of the nature of the entity's operations and principal activities." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_DescriptionOfReasonWhyPresentationCurrencyIsDifferentFromFunctionalCurrency": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfReasonWhyPresentationCurrencyIsDifferentFromFunctionalCurrency", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convenience translation description" } }, "en": { "role": { "documentation": "The description of the reason why the currency in which the financial statements are presented is different from the currency of the primary economic environment in which the entity operates." } } }, "auth_ref": [ "r70" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r186" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r91", "r92" ] }, "GDTC_DirectorsFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DirectorsFeesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Directors Fees [member]", "documentation": "Directors Fees [member]" } } }, "auth_ref": [] }, "GDTC_DirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DirectorsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Directors [member]", "documentation": "Directors [member]" } } }, "auth_ref": [] }, "ifrs-full_DirectorsRemunerationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DirectorsRemunerationExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails": { "parentTag": "ifrs-full_ShorttermEmployeeBenefitsExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Directors\u2019 fees" } }, "en": { "role": { "documentation": "The amount of remuneration paid or payable to the entity's directors." } } }, "auth_ref": [ "r393" ] }, "GDTC_DisclosureCapitalReserveAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureCapitalReserveAbstract", "lang": { "en-us": { "role": { "label": "Capital Reserve" } } }, "auth_ref": [] }, "GDTC_DisclosureContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureContractLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Contract Liabilities", "verboseLabel": "Schedule Of Contract Liabilities" } } }, "auth_ref": [] }, "GDTC_DisclosureHoldingCompanyAndRelatedCompanyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureHoldingCompanyAndRelatedCompanyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Holding Company And Related Company Transactions" } } }, "auth_ref": [] }, "GDTC_DisclosureMaterialAccountingPolicyInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureMaterialAccountingPolicyInformationAbstract", "lang": { "en-us": { "role": { "label": "Material Accounting Policy Information" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY" } }, "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r388" ] }, "GDTC_DisclosureOfAccountingPolicyForBasisOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfAccountingPolicyForBasisOfConsolidationExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "BASIS OF CONSOLIDATION", "documentation": "Description of accounting policy for basis of consolidation explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfAccountingPolicyForBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfAccountingPolicyForBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationPolicies" ], "lang": { "en-us": { "role": { "label": "BASIS OF PREPARATION", "documentation": "Description of accounting policy for basis of preparation of financial statements explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities." } } }, "auth_ref": [ "r74" ] }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF REMAINING CONTRACTUAL MATURITIES" } }, "en": { "role": { "documentation": "The disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } } }, "auth_ref": [ "r20" ] }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } } }, "auth_ref": [ "r20" ] }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfBorrowingsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/Borrowings" ], "lang": { "en-us": { "role": { "label": "BORROWINGS" } }, "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r388" ] }, "GDTC_DisclosureOfCapitalReserveExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfCapitalReserveExplanatory", "presentation": [ "http://w2.cytomed.sg/role/CapitalReserve" ], "lang": { "en-us": { "role": { "label": "CAPITAL RESERVE", "documentation": "Disclosure of capital reserve explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfCashAndBankBalanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfCashAndBankBalanceAbstract", "auth_ref": [] }, "GDTC_DisclosureOfCashAndBankBalanceLineItem": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfCashAndBankBalanceLineItem", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DisclosureOfCashAndBankBalanceLineItem [Line Items]" } } }, "auth_ref": [] }, "GDTC_DisclosureOfCashAndBankBalanceTable": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfCashAndBankBalanceTable", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "DisclosureOfCashAndBankBalanceTable [Table]" } } }, "auth_ref": [] }, "GDTC_DisclosureOfCashAndCashEquivalentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfCashAndCashEquivalentExplanatory", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CASH AND CASH EQUIVALENTS", "documentation": "Disclosure of cash and cash equivalent explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalances" ], "lang": { "en-us": { "role": { "label": "CASH AND BANK BALANCES" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfCashFlowStatementExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of cash flow statement [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } } }, "auth_ref": [ "r130" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ShareCapital" ], "lang": { "en-us": { "role": { "label": "SHARE CAPITAL" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]" } } }, "auth_ref": [ "r27" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r27" ] }, "ifrs-full_DisclosureOfCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfCommitmentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/Commitments" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS" } }, "en": { "role": { "documentation": "The disclosure of commitments." } } }, "auth_ref": [ "r388" ] }, "GDTC_DisclosureOfContractLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfContractLiabilitiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ContractLiabilities" ], "lang": { "en-us": { "role": { "label": "CONTRACT LIABILITIES", "documentation": "The disclosure of contract liabilities." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCreditRiskExposureExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfCreditRiskExposureExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CURRENCY EXPOSURE BASED ON THE INFORMATION" } }, "en": { "role": { "documentation": "The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity\u2019s financial assets and commitments to extend credit." } } }, "auth_ref": [ "r196" ] }, "ifrs-full_DisclosureOfDepreciationAndAmortisationExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEPRECIATION EXPENSE" } }, "en": { "role": { "documentation": "The disclosure of depreciation and amortisation expense. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BORROWINGS" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r414" ] }, "GDTC_DisclosureOfDetailedInformationAboutCapitalCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutCapitalCommitmentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/CommitmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CAPITAL COMMITMENTS", "documentation": "Disclosure of detailed information about capital commitments explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutContractLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutContractLiabilitiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ContractLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONTRACT LIABILITIES", "documentation": "Disclosure of detailed information about contract liabilities." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutCurrentIncomeTaxExpensesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutCurrentIncomeTaxExpensesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpenseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CURRENT INCOME TAX EXPENSES", "documentation": "The disclosure of detailed information about current income tax expenses." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutEmployeeBenefitsExpensesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutEmployeeBenefitsExpensesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/EmployeeBenefitsExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EMPLOYEE BENEFITS EXPENSES", "documentation": "Disclosure of detailed information about employee benefits expenses explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutFinanceIncomeExpenseExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinanceExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCE EXPENSES", "documentation": "Disclosure of detailed information about finance income expense explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutFinancialAssetsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialAssetsAtFvociTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL ASSETS", "documentation": "The disclosure of detailed information about financial assets." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutIncomeTaxExpensesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutIncomeTaxExpensesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpenseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INCOME TAX EXPENSES", "documentation": "The disclosure of detailed information about income tax expenses." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutInterestRateChangesAndContractualRepaymentDates": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutInterestRateChangesAndContractualRepaymentDates", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BORROWING OF THE GROUP TO INTEREST RATE CHANGES AND CONTRACTUAL REPAYMENT DATES", "documentation": "Disclosure of detailed information about interest rate changes and contractual repayment dates." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutOperatingLeaseCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutOperatingLeaseCommitmentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/CommitmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPERATING LEASE COMMITMENTS", "documentation": "Disclosure of detailed information about operating lease commitments explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "presentation": [ "http://w2.cytomed.sg/role/LeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LEASE LIABILITIES", "documentation": "Disclosure of detailed information about operating lease liabilities." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutOtherExpensesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutOtherExpensesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/OtherExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER EXPENSES", "documentation": "Disclosure of detailed information about other expenses explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutOtherGainLossNetExplanatory", "presentation": [ "http://w2.cytomed.sg/role/OtherLossesgainsIncludingFairValueChangesOnFinancialInstruments-NetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER (LOSSES)/GAINS - NET", "documentation": "Disclosure of detailed information about other gain loss net explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutOtherOperatingIncomeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutOtherOperatingIncomeExplanatory", "presentation": [ "http://w2.cytomed.sg/role/OtherOperatingIncomeTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER OPERATING INCOME", "documentation": "Disclosure of detailed information about other operating income explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r59" ] }, "GDTC_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpensesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpensesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ResearchExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RESEARCH EXPENSES", "documentation": "Disclosure of detailed information about research and development expenses explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserveTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE-BASED PAYMENT RESERVE", "documentation": "The entire disclosure for detailed information about share-based payment arrangements." } } }, "auth_ref": [] }, "GDTC_DisclosureOfDetailedInformationAboutsStatementOfFinancialPositionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfDetailedInformationAboutsStatementOfFinancialPositionExplanatory", "presentation": [ "http://w2.cytomed.sg/role/LeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONSOLIDATED STATEMENT OF FINANCIAL POSITIONS", "documentation": "Disclosure of detailed information abouts statement of financial position explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://w2.cytomed.sg/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DISAGGREGATION OF REVENUE FROM CONTRACTS WITH CUSTOMERS" } }, "en": { "role": { "documentation": "The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]" } } }, "auth_ref": [ "r162" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfEmployeeBenefitsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/EmployeeBenefitsExpenses" ], "lang": { "en-us": { "role": { "label": "EMPLOYEE BENEFITS EXPENSES" } }, "en": { "role": { "documentation": "The entire disclosure for employee benefits." } } }, "auth_ref": [ "r66" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/SegmentInformation" ], "lang": { "en-us": { "role": { "label": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r226" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDate" ], "lang": { "en-us": { "role": { "label": "EVENTS OCCURRING AFTER BALANCE SHEET DATE" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r44" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails", "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE OF WARRANTS" } }, "en": { "role": { "documentation": "The disclosure of the fair value measurement of liabilities." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of liabilities." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinanceExpenses" ], "lang": { "en-us": { "role": { "label": "FINANCE EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinancialAssetsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialAssetsAtFvoci" ], "lang": { "en-us": { "role": { "label": "FINANCIAL ASSETS, AT FVOCI" } }, "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r201" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EACH CLASS OF FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE" } }, "en": { "role": { "documentation": "The disclosure of financial instruments measured at fair value through profit or loss. [Refer: At fair value [member]; Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial instruments [text block]", "verboseLabel": "SCHEDULE OF FINANCIAL INSTRUMENTS" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r208" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsTable", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } } }, "auth_ref": [ "r192", "r195", "r201" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r201" ] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagement" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS, FINANCIAL RISKS AND CAPITAL RISKS MANAGEMENT" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/General" ], "lang": { "en-us": { "role": { "label": "GENERAL" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r9" ] }, "ifrs-full_DisclosureOfGeographicalAreasExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfGeographicalAreasExplanatory", "presentation": [ "http://w2.cytomed.sg/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GEOGRAPHICAL INFORMATION IN NON-CURRENT ASSETS" } }, "en": { "role": { "documentation": "The disclosure of geographical information." } } }, "auth_ref": [ "r224" ] }, "GDTC_DisclosureOfHoldingCompanyAndRelatedCompanyTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfHoldingCompanyAndRelatedCompanyTransactionsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/HoldingCompanyAndRelatedCompanyTransactions" ], "lang": { "en-us": { "role": { "label": "HOLDING COMPANY AND RELATED COMPANY TRANSACTIONS", "documentation": "Disclosure of holding company and related company transactions explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpense" ], "lang": { "en-us": { "role": { "label": "INCOME TAX EXPENSE" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r50" ] }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "presentation": [ "http://w2.cytomed.sg/role/SignificantRelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF REMUNERATION OF DIRECTORS AND KEY MANAGEMENT PERSONNEL" } }, "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfIntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [abstract]" } } }, "auth_ref": [] }, "GDTC_DisclosureOfIntangibleAssetsAmortizationExpensesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfIntangibleAssetsAmortizationExpensesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF AMORTIZATION EXPENSE", "documentation": "Disclosure of intangible assets amortization expenses explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTANGIBLE ASSETS" } }, "en": { "role": { "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS" } }, "en": { "role": { "documentation": "The entire disclosure for intangible assets." } } }, "auth_ref": [ "r111" ] }, "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsMaterialToEntityExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DETAILED INFORMATION ABOUT INTANGIBLE ASSETS" } }, "en": { "role": { "documentation": "The disclosure of intangible assets that are material to the entity. [Refer: Intangible assets material to entity]" } } }, "auth_ref": [ "r109" ] }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfIntangibleAssetsTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } } }, "auth_ref": [ "r108" ] }, "GDTC_DisclosureOfInvestmentInAssociateExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfInvestmentInAssociateExplanatory", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVESTMENT IN ASSOCIATE", "documentation": "Disclosure of investment in associate explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociate" ], "lang": { "en-us": { "role": { "label": "INVESTMENT IN AN ASSOCIATE" } }, "en": { "role": { "documentation": "The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/LeaseLiabilities" ], "lang": { "en-us": { "role": { "label": "LEASE LIABILITIES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r176", "r177" ] }, "GDTC_DisclosureOfMaterialsAccountingPolicyInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfMaterialsAccountingPolicyInformationExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformation" ], "lang": { "en-us": { "role": { "label": "MATERIAL ACCOUNTING POLICY INFORMATION", "documentation": "Disclosure of materials accounting policy information explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/CommitmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FUTURE MINIMUM PAYMENTS UNDER NON-CANCELLABLE" } }, "en": { "role": { "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } } }, "auth_ref": [ "r175" ] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CAPITAL BASED ON DEBT-TO-EQUITY RATIO" } }, "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r192" ] }, "GDTC_DisclosureOfNetFinancialLiabilityAssetCurrencyRiskExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfNetFinancialLiabilityAssetCurrencyRiskExplanatory", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF NET FINANCIAL LIABILITY ASSET CURRENCY RISK", "documentation": "Disclosure of net financial liability asset currency risk explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfNoncontrollingInterestsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/GeneralTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL INFORMATION OF NON-CONTROLLING INTERESTS" } }, "en": { "role": { "documentation": "The disclosure of non-controlling interests. [Refer: Non-controlling interests]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "presentation": [ "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BUSINESS SEGMENT" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r214" ] }, "GDTC_DisclosureOfOtherGainLossNetExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfOtherGainLossNetExplanatory", "presentation": [ "http://w2.cytomed.sg/role/OtherLossesgainsIncludingFairValueChangesOnFinancialInstruments-Net" ], "lang": { "en-us": { "role": { "label": "OTHER (LOSSES)/GAINS INCLUDING FAIR VALUE CHANGES ON FINANCIAL INSTRUMENTS - NET", "documentation": "Disclosure of other gain loss net explanatory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfOtherOperatingExpenseExplanatory", "presentation": [ "http://w2.cytomed.sg/role/OtherExpenses" ], "lang": { "en-us": { "role": { "label": "OTHER EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfOtherOperatingIncomeExplanatory", "presentation": [ "http://w2.cytomed.sg/role/OtherOperatingIncome" ], "lang": { "en-us": { "role": { "label": "OTHER OPERATING INCOME" } }, "en": { "role": { "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r388" ] }, "GDTC_DisclosureOfOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfOtherReceivablesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/TradeAndOtherReceivablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TRADE AND OTHER RECEIVABLES", "documentation": "Disclosure of other receivables explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPerformanceObligationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfPerformanceObligationsTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of performance obligations [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to performance obligations in contracts with customers." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [abstract]" } } }, "auth_ref": [] }, "GDTC_DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY PLANT AND EQUIPMENT ESTIMATED USEFUL LIVES", "documentation": "Disclosure of property plant and equipment estimated useful life explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "PROPERTY, PLANT AND EQUIPMENT" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r62" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative", "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r187" ] }, "GDTC_DisclosureOfReconciliationOfFinancialInformationInInvestmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfReconciliationOfFinancialInformationInInvestmentExplanatory", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATION OF FINANCIAL INFORMATION IN INVESTMENT", "documentation": "Disclosure of reconciliation of financial information in investment explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivities" ], "lang": { "en-us": { "role": { "label": "RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities." } } }, "auth_ref": [ "r253" ] }, "GDTC_DisclosureOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RECONCILIATIONS OF LIABILITIES ARISING FROM FINANCING ACTIVITIES", "documentation": "Disclosure of reconciliations of liabilities arising from financing activities explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://w2.cytomed.sg/role/SignificantRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT RELATED PARTY TRANSACTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r78" ] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ResearchExpenses" ], "lang": { "en-us": { "role": { "label": "RESEARCH EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfRevenueExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfRevenueExplanatory", "presentation": [ "http://w2.cytomed.sg/role/Revenue" ], "lang": { "en-us": { "role": { "label": "REVENUE" } }, "en": { "role": { "documentation": "The entire disclosure for revenue." } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ShareCapitalTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]", "verboseLabel": "SCHEDULE OF SHARE CAPITAL" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r28" ] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserve" ], "lang": { "en-us": { "role": { "label": "SHARE-BASED PAYMENT RESERVE" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r183" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInAssociatesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF KEY ASSUMPTIONS OF INVESTMENT IN ASSOCIATE" } }, "en": { "role": { "documentation": "The disclosure of associates. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r86", "r90", "r154" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of associates [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to associates." } } }, "auth_ref": [ "r86", "r90", "r154" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/GeneralTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PRINCIPAL ACTIVITIES OF SUBSIDIARIES" } }, "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r86", "r90", "r153" ] }, "GDTC_DisclosureOfSummarizedFinancialInformationOfMaterialAssociatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfSummarizedFinancialInformationOfMaterialAssociatesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL INFORMATION INVESTMENT IN ASSOCIATE", "documentation": "Disclosure of summarized financial information of material associates explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [abstract]" } } }, "auth_ref": [] }, "GDTC_DisclosureOfTradeAndOtherPayablesDetailsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfTradeAndOtherPayablesDetailsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/TradeAndOtherPayablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TRADE AND OTHER PAYABLES", "documentation": "Disclosure of trade and other payables details explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/TradeAndOtherPayables" ], "lang": { "en-us": { "role": { "label": "TRADE AND OTHER PAYABLES" } }, "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/TradeAndOtherReceivables" ], "lang": { "en-us": { "role": { "label": "TRADE AND OTHER RECEIVABLES" } }, "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_DisclosureOfTransactionPriceAllocatedToRemainingPerformanceObligationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfTransactionPriceAllocatedToRemainingPerformanceObligationsExplanatory", "presentation": [ "http://w2.cytomed.sg/role/ContractLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNSATISFIED PERFORMANCE OBLIGATIONS" } }, "en": { "role": { "documentation": "The disclosure of the transaction price allocated to the remaining performance obligations in contracts with customers." } } }, "auth_ref": [ "r166" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/SignificantRelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RELATED PARTY TRANSACTIONS" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r73" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails", "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r76" ] }, "GDTC_DisclosureOfUnutilizedTaxLossesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfUnutilizedTaxLossesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpenseTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNUTILIZED TAX LOSSES", "documentation": "Disclosure of unutilized tax losses explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOfWarrantLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOfWarrantLiabilitiesExplanatory", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT LIABILITIES", "documentation": "Disclosure of warrant liabilities explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureOtherLossesgainsIncludingFairValueChangesOnFinancialInstrumentsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureOtherLossesgainsIncludingFairValueChangesOnFinancialInstrumentsNetAbstract", "lang": { "en-us": { "role": { "label": "Other Lossesgains Including Fair Value Changes On Financial Instruments - Net", "verboseLabel": "Schedule Of Other Lossesgains - Net" } } }, "auth_ref": [] }, "GDTC_DisclosureWarrantLiabilitiesAndWarrantReserveAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureWarrantLiabilitiesAndWarrantReserveAbstract", "lang": { "en-us": { "role": { "label": "Warrant Liabilities And Warrant Reserve", "verboseLabel": "Schedule Of Warrant Liabilities", "terseLabel": "Schedule Of Warrant Reserve" } } }, "auth_ref": [] }, "GDTC_DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureWarrantLiabilitiesAndWarrantReserveExplanatory", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserve" ], "lang": { "en-us": { "role": { "label": "WARRANT LIABILITIES AND WARRANT RESERVE", "documentation": "Disclosure warrant liabilities and warrant reserve explanatory." } } }, "auth_ref": [] }, "GDTC_DisclosureWarrantReserveExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "DisclosureWarrantReserveExplanatory", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT RESERVE", "documentation": "Disclosure warrant reserve explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Written off", "label": "Disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r54" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r290" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r288", "r290", "r311" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r288", "r290", "r311", "r351" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r289" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r277" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r290" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r290" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r336" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r280" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effects of foreign currency translation on cash and cash equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r120", "r121" ] }, "GDTC_EffectiveInterestRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "EffectiveInterestRatePercentage", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective interest rate percentage", "documentation": "Effective interest rate percentage" } } }, "auth_ref": [] }, "ifrs-full_EmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Employee benefits expenses", "verboseLabel": "Total", "label": "Employee benefits expense" } }, "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r0", "r42", "r229" ] }, "GDTC_EmployeeBenefitsUnderResearchExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "EmployeeBenefitsUnderResearchExpenses", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "\u201cResearch expenses\u201d (Note 21)", "documentation": "Employee benefits under research expenses.", "label": "EmployeeBenefitsUnderResearchExpenses" } } }, "auth_ref": [] }, "GDTC_EntertainmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "EntertainmentExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Entertainment", "documentation": "Entertainment expense." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesLineItems", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesTable", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r279" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r283" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r279" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r279" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r387" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r279" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r384" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r311" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r279" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r279" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r279" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r279" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r385" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Total equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r18", "r24", "r131", "r133", "r155", "r156", "r157" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Capital and reserves" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r18" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Equity attributable to owners of the equity", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r17" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r5" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r344" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r304", "r315", "r329", "r355" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r301", "r312", "r326", "r352" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r350" ] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "label": "Exercise price of outstanding share options" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r185" ] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r186" ] }, "GDTC_ExercisePriceShareSpotPrice": { "xbrltype": "perShareItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ExercisePriceShareSpotPrice", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Spot price", "documentation": "Exercise price share spot price." } } }, "auth_ref": [] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails": { "parentTag": "ifrs-full_ShorttermEmployeeBenefitsExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails", "http://w2.cytomed.sg/role/ScheduleOfShare-basedPaymentReserveDetails" ], "lang": { "en-us": { "role": { "label": "Share-based payment to employees (Note 22)", "verboseLabel": "Share-based compensation" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r393" ] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithPartiesOtherThanEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithPartiesOtherThanEmployees", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails", "http://w2.cytomed.sg/role/ScheduleOfShare-basedPaymentReserveDetails" ], "lang": { "en-us": { "role": { "label": "Share-based payment to advisors", "verboseLabel": "Share-based payment expenses" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with parties other than employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r393" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "GDTC_FairValueAdjustmentsOfNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueAdjustmentsOfNoncontrollingInterests", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Less: fair value adjustments", "documentation": "Fair value adjustments of noncontrolling interests." } } }, "auth_ref": [] }, "GDTC_FairValueChangesOnWarrantLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueChangesOnWarrantLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": 1.0, "order": 7.0 }, "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value changes on warrant liabilities", "label": "Fair value changes on warrant liabilities (Note 14)", "documentation": "Fair value changes on warrant liabilities" } } }, "auth_ref": [] }, "GDTC_FairValueChangesToNumberOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueChangesToNumberOfWarrants", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair value changes to profit or loss, Number of Warrants", "documentation": "Fair value changes to number of warrants." } } }, "auth_ref": [] }, "GDTC_FairValueChangesToProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueChangesToProfitOrLoss", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair value changes to profit or loss, Amount", "documentation": "Fair value changes to profit or loss." } } }, "auth_ref": [] }, "GDTC_FairValueLossGainOnConvertibleLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueLossGainOnConvertibleLoans", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value losses on convertible loans", "documentation": "Fair value (loss)/gain on convertible loans.", "label": "FairValueLossGainOnConvertibleLoans" } } }, "auth_ref": [] }, "GDTC_FairValueOfWarrant": { "xbrltype": "perShareItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueOfWarrant", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of warrant", "documentation": "Fair value of warrant." } } }, "auth_ref": [] }, "GDTC_FairValueOnWarrantLiabilitiesAtInceptionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueOnWarrantLiabilitiesAtInceptionDate", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value on warrant liabilities at inception date", "documentation": "Fair value on warrant liabilities at inception date.", "label": "FairValueOnWarrantLiabilitiesAtInceptionDate" } } }, "auth_ref": [] }, "GDTC_FairValueOnWarrantsLiabilitiesAtInceptionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FairValueOnWarrantsLiabilitiesAtInceptionDate", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails" ], "lang": { "en-us": { "role": { "label": "Fair value on warrant liabilities at inception date (Note 14)", "documentation": "Fair value on warrants liabilities at inception date." } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 9.0 }, "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Finance expenses", "totalLabel": "Total", "label": "Finance costs" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r35" ] }, "GDTC_FinancialAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FinancialAssetMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Financial asset [member]", "documentation": "Financial asset [member]" } } }, "auth_ref": [] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Financial assets, at FVOCI", "verboseLabel": "Financial assets" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]" } } }, "auth_ref": [ "r191", "r193", "r194", "r196", "r269" ] }, "ifrs-full_FinancialAssetsAtAmortisedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialAssetsAtAmortisedCost", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at amortized cost" } }, "en": { "role": { "documentation": "The amount of financial assets at amortised cost. The amortised cost is the amount at which financial assets are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount, and adjusted for any impairment. [Refer: Financial assets]" } } }, "auth_ref": [ "r203" ] }, "ifrs-full_FinancialAssetsAtAmortisedCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialAssetsAtAmortisedCostMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at amortised cost, class [member]" } }, "en": { "role": { "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]" } } }, "auth_ref": [ "r206" ] }, "GDTC_FinancialAssetsAtFVOCIMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FinancialAssetsAtFVOCIMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at FVOCI [member]", "documentation": "Financial assets at FVOCI [member]" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r191" ] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCost", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at amortized cost" } }, "en": { "role": { "documentation": "The amount of financial liabilities at amortised cost. The amortised cost is the amount at which financial liabilities are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r204" ] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCostMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at amortised cost, class [member]" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]" } } }, "auth_ref": [ "r206" ] }, "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at fair value through profit or loss, category [member]" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities at fair value through profit or loss category. [Refer: Financial liabilities at fair value through profit or loss]" } } }, "auth_ref": [ "r202" ] }, "GDTC_FinancialLiabilitiesAtFvtpl": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FinancialLiabilitiesAtFvtpl", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at FVTPL", "documentation": "Financial liabilities at FVTPL ." } } }, "auth_ref": [] }, "GDTC_FinancialsLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FinancialsLiabilitiesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Financials liabilities [member]", "documentation": "Financials liabilities [member]" } } }, "auth_ref": [] }, "GDTC_FixedDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FixedDeposit", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Less: Fixed deposits with maturities over 3 months", "documentation": "Fixed deposit" } } }, "auth_ref": [] }, "GDTC_FixedDepositTerm": { "xbrltype": "durationItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FixedDepositTerm", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fixed deposit term", "documentation": "Fixed deposit term" } } }, "auth_ref": [] }, "ifrs-full_FixturesAndFittingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FixturesAndFittingsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Fixtures and fittings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r237" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r308", "r319", "r333", "r359" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r308", "r319", "r333", "r359" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r308", "r319", "r333", "r359" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r308", "r319", "r333", "r359" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r308", "r319", "r333", "r359" ] }, "GDTC_FreeholdLandAndBuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FreeholdLandAndBuildingMember", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Freehold land and building [member]", "documentation": "Freehold land and building [member]" } } }, "auth_ref": [] }, "GDTC_FreeholdLandMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FreeholdLandMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Freehold land [member]", "documentation": "Freehold land [member]" } } }, "auth_ref": [] }, "ifrs-full_FunctionalOrPresentationCurrencyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "FunctionalOrPresentationCurrencyMember", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en": { "role": { "documentation": "This member indicates information displayed in the functional or presentation currency. It also represents the standard value for the \u2018Currency in which information is displayed\u2019 axis if no other member is used." } } }, "auth_ref": [ "r71" ] }, "GDTC_FurnitureAndFittingsEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "FurnitureAndFittingsEquipmentMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and fittings equipment [member]", "documentation": "Furniture and fittings equipment [member]" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnDisposalsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "GainsLossesOnDisposalsOfInvestments", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on disposal of associate", "label": "Gains (losses) on disposals of investments" } }, "en": { "role": { "documentation": "The gains (losses) on disposals of investments." } } }, "auth_ref": [ "r41" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation (loss)/gain" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Foreign currency exchange (loss)/gain - net", "verboseLabel": "Foreign exchange gain (loss)" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r8", "r68" ] }, "ifrs-full_GainsOnDisposalsOfInvestments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "GainsOnDisposalsOfInvestments", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails" ], "lang": { "en-us": { "role": { "label": "Gain on disposal of investment in an associate" } }, "en": { "role": { "documentation": "The gain on the disposal of investments." } } }, "auth_ref": [ "r41" ] }, "GDTC_GeneralAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "GeneralAbstract", "lang": { "en-us": { "role": { "label": "General" } } }, "auth_ref": [] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "ifrs-full_IntangibleAssetsAndGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r11", "r98", "r100", "r187" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r52", "r102", "r114", "r117", "r187", "r194", "r196", "r269" ] }, "GDTC_GroupShareOfNetAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "GroupShareOfNetAssets", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Group share of net assets", "documentation": "Group share of net assets." } } }, "auth_ref": [] }, "GDTC_HiringIncentiveAndTrainingProgrammeMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "HiringIncentiveAndTrainingProgrammeMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Hiring incentive and training programme [member]", "documentation": "Hiring incentive and training programme [member]" } } }, "auth_ref": [] }, "GDTC_IPSCDepositorySdnBhdMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IPSCDepositorySdnBhdMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "IPSC Depository Sdn Bhd [member]", "documentation": "IPSC Depository Sdn Bhd [member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r288", "r290", "r311" ] }, "GDTC_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IfrsStatementLineItems", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative", "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative", "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative", "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails", "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails", "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails", "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails", "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical", "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails", "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "GDTC_ImmuneCellTherapyMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ImmuneCellTherapyMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Immune cell therapy [member]", "documentation": "Immune cell therapy [member]" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ImpairmentLoss", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment loss" } }, "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r95", "r96" ] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Written off of intangible asset" } }, "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r104" ] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Written off of property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]" } } }, "auth_ref": [ "r39", "r55" ] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expense", "negatedTerseLabel": "Income tax expenses", "totalLabel": "Income tax expenses", "label": "Tax expense (income)" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r37", "r45", "r46", "r47", "r81", "r152", "r213" ] }, "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax paid", "label": "Income taxes paid (refund), classified as operating activities" } }, "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]" } } }, "auth_ref": [ "r123", "r246" ] }, "GDTC_IncreaseDecreaseConversionOfConvertibleUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IncreaseDecreaseConversionOfConvertibleUnits", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Conversion of ordinary shares", "documentation": "Increase decrease conversion of convertible units.", "label": "IncreaseDecreaseConversionOfConvertibleUnits" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase/(decrease) in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r127" ] }, "ifrs-full_IncreaseDecreaseInFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseInFinancialAssets", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } }, "en": { "role": { "documentation": "The increase (decrease) in financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r193", "r194" ] }, "GDTC_IncreaseDecreaseInWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IncreaseDecreaseInWarrantLiability", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase decrease in warrant liability", "documentation": "Increase decrease in warrant liability." } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughChangeInEquityOfSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughChangeInEquityOfSubsidiaries", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Effect of dilution of interest in subsidiaries" } }, "en": { "role": { "documentation": "The increase (decrease) in the entity's equity resulting from the change in the equity of subsidiaries. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r391" ] }, "ifrs-full_IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value changes", "label": "Increase (decrease) through changes in fair values, liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes in fair values. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r125" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Warrant exercised before year end" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } } }, "auth_ref": [ "r391" ] }, "ifrs-full_IncreaseDecreaseThroughLossOfControlOfSubsidiaryDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughLossOfControlOfSubsidiaryDeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Increase/(decrease) Loss after tax" } }, "en": { "role": { "documentation": "The decrease in deferred tax liability (asset) resulting from the loss of control of a subsidiary. [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_IncreaseDecreaseThroughModificationOfContractualCashFlowsExposureToCreditRiskOnLoanCommitmentsAndFinancialGuaranteeContracts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughModificationOfContractualCashFlowsExposureToCreditRiskOnLoanCommitmentsAndFinancialGuaranteeContracts", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase decrease in loan" } }, "en": { "role": { "documentation": "The increase (decrease) in exposure to credit risk on loan commitments and financial guarantee contracts resulting from the modification of contractual cash flows. [Refer: Exposure to credit risk on loan commitments and financial guarantee contracts]" } } }, "auth_ref": [ "r268" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency realignment", "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r106" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Currency realignment" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r57" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share-based payment", "verboseLabel": "Capitalization of share-based payment reserve" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r3" ] }, "GDTC_IncreaseDecreaseThroughWarrantReserveCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IncreaseDecreaseThroughWarrantReserveCapitalized", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfWarrantReserveDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrant reserve capitalized in the year", "label": "Warrant reserve to share capital", "documentation": "Increase decrease through warrant reserve capitalized." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r308", "r319", "r333", "r350", "r359", "r363", "r371" ] }, "GDTC_InformationTechnologyExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "InformationTechnologyExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "IT expenses", "documentation": "Information technology expense." } } }, "auth_ref": [] }, "GDTC_InitialPublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "InitialPublicOfferingMember", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Initial public offering [member]", "documentation": "Initial public offering [member]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r369" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r291", "r374" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r291", "r374" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r291", "r374" ] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Company insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_IntangibleAssetsAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IntangibleAssetsAndGoodwill", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Intangible assets and goodwill" } }, "en": { "role": { "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r395" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "periodStartLabel": "At beginning of financial year", "periodEndLabel": "At end of financial year" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r11", "r107" ] }, "ifrs-full_IntangibleAssetsUnderDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IntangibleAssetsUnderDevelopment", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "ifrs-full_IntangibleAssetsAndGoodwill", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Acquired customer relationship (Note (c))" } }, "en": { "role": { "documentation": "The amount of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r245" ] }, "GDTC_IntellectualPropertiesLicensesMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IntellectualPropertiesLicensesMember", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intellectual properties licenses [member]", "documentation": "Intellectual properties licenses [member]" } } }, "auth_ref": [] }, "ifrs-full_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest expense" } }, "en": { "role": { "documentation": "The amount of expense arising from interest." } } }, "auth_ref": [ "r151", "r211", "r219" ] }, "ifrs-full_InterestExpenseOnBankLoansAndOverdrafts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestExpenseOnBankLoansAndOverdrafts", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Bank borrowings" } }, "en": { "role": { "documentation": "The amount of interest expense on bank loans and overdrafts. [Refer: Interest expense; Bank overdrafts]" } } }, "auth_ref": [ "r393" ] }, "ifrs-full_InterestExpenseOnBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestExpenseOnBorrowings", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense on borrowings", "label": "Interest expense on borrowings" } }, "en": { "role": { "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]" } } }, "auth_ref": [ "r393" ] }, "ifrs-full_InterestExpenseOnDebtInstrumentsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestExpenseOnDebtInstrumentsIssued", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities (Note 13)" } }, "en": { "role": { "documentation": "The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]" } } }, "auth_ref": [ "r393" ] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Interest charged (Note 23)" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r170" ] }, "GDTC_InterestExpenseOnRelatedPartyLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "InterestExpenseOnRelatedPartyLoan", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Third party loan", "documentation": "Interest expense on related party loan." } } }, "auth_ref": [] }, "GDTC_InterestExpenseOnThirdPartyLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "InterestExpenseOnThirdPartyLoan", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Convertible loans", "documentation": "Interest Expense on Third Party Loan." } } }, "auth_ref": [] }, "ifrs-full_InterestPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest paid", "label": "Interest paid, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as financing activities." } } }, "auth_ref": [ "r122" ] }, "ifrs-full_InterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestReceivable", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Interest receivables" } }, "en": { "role": { "documentation": "The amount of interest recognised as a receivable." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestReceivedClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest received", "label": "Interest received, classified as investing activities" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as investing activities." } } }, "auth_ref": [ "r122" ] }, "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InterestReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest received" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as operating activities." } } }, "auth_ref": [ "r122" ] }, "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Investment in an associate", "periodStartLabel": "Beginning of financial year", "periodEndLabel": "End of financial year", "verboseLabel": "Carrying value" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]" } } }, "auth_ref": [ "r82" ] }, "GDTC_InvestmentsInSubsidiariesJointVenturesAndAssociatesCurrencyRealignment": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociatesCurrencyRealignment", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Currency realignment", "documentation": "Investments in subsidiaries joint ventures and associates currency realignment.", "label": "InvestmentsInSubsidiariesJointVenturesAndAssociatesCurrencyRealignment" } } }, "auth_ref": [] }, "GDTC_InvestorRelationsExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "InvestorRelationsExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Investor relations expenses" } } }, "auth_ref": [] }, "GDTC_IssuanceOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IssuanceOfOrdinaryShares", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of ordinary shares", "documentation": "Issuance of ordinary shares", "label": "Issuance of ordinary shares [Default Label]" } } }, "auth_ref": [] }, "GDTC_IssuanceOfOrdinarySharesFromTheExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "IssuanceOfOrdinarySharesFromTheExerciseOfWarrants", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of ordinary shares from the exercise of warrants", "documentation": "Issuance of ordinary shares from the exercise of warrants." } } }, "auth_ref": [] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of shares", "verboseLabel": "Aggregate value" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Share capital", "verboseLabel": "Issued capital, amount", "terseLabel": "Sale of stock, shares" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r234" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r5" ] }, "GDTC_LaboratoryEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LaboratoryEquipmentMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Laboratory equipment [member]", "documentation": "Laboratory equipment [member]" } } }, "auth_ref": [] }, "ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanFiveYearsAndNotLaterThanTenYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Later than five years and not later than ten years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years and not later than ten years." } } }, "auth_ref": [ "r271", "r274", "r393" ] }, "ifrs-full_LaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanFiveYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years." } } }, "auth_ref": [ "r173", "r175", "r181", "r271", "r272", "r274" ] }, "ifrs-full_LaterThanOneMonthAndNotLaterThanSixMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanOneMonthAndNotLaterThanSixMonthsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails" ], "lang": { "en-us": { "role": { "label": "Later than one month and not later than six months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one month and not later than six months." } } }, "auth_ref": [ "r271", "r274" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than five years." } } }, "auth_ref": [ "r270", "r274" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than two years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } } }, "auth_ref": [ "r173", "r175", "r181", "r271", "r274", "r393" ] }, "GDTC_LaterThanOneYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LaterThanOneYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Later than one years and not later than five years [member]", "documentation": "Later than one years and not later than five years [member]" } } }, "auth_ref": [] }, "GDTC_LaterThanSixMonthAndNotLaterThanTwelveMonthsMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LaterThanSixMonthAndNotLaterThanTwelveMonthsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails" ], "lang": { "en-us": { "role": { "label": "6 \u0096 12 months [member]", "documentation": "Later than six month and not later than twelve months [member]" } } }, "auth_ref": [] }, "ifrs-full_LaterThanTenYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanTenYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Later than ten years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than ten years." } } }, "auth_ref": [ "r271", "r274", "r393" ] }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LaterThanTwoYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than two years and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than five years." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails", "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfLeaseLiabilitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "At beginning of year", "periodEndLabel": "At end of year", "totalLabel": "Total", "verboseLabel": "Total", "terseLabel": "Lease liabilities", "negatedLabel": "Lease liabilities", "label": "Lease liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r169" ] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r252", "r255" ] }, "GDTC_LegalFeesExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LegalFeesExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Legal fees", "documentation": "Legal fees expenses." } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r64", "r97", "r99", "r156" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r97", "r99", "r156" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r97", "r99", "r156" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r64", "r156" ] }, "ifrs-full_LevelsOfFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r64", "r156" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "periodEndLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r18", "r155", "r156", "r157", "r214", "r218" ] }, "ifrs-full_LiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Liabilities arising from financing activities at beginning of period", "periodEndLabel": "Liabilities arising from financing activities at end of period", "label": "Liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LiabilitiesArisingFromFinancingActivitiesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities arising from financing activities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r253" ] }, "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LiabilitiesArisingFromFinancingActivitiesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_LicencesAndFranchises": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LicencesAndFranchises", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "ifrs-full_IntangibleAssetsAndGoodwill", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Acquired private blood bank license (Note (d))" } }, "en": { "role": { "documentation": "The amount of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r242" ] }, "ifrs-full_LicencesAndFranchisesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LicencesAndFranchisesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails", "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Licences and franchises [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity and the right to operate a business using the name, merchandise, services, methodologies, promotional support, marketing and supplies granted by another entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r242" ] }, "GDTC_LicencingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LicencingAgreementMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails" ], "lang": { "en-us": { "role": { "label": "Licencing agreement [member]", "documentation": "Licencing agreement [member]" } } }, "auth_ref": [] }, "GDTC_LoanReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LoanReceivable", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Loan receivable", "documentation": "Loan receivable." } } }, "auth_ref": [] }, "GDTC_LoanToThirdParty": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LoanToThirdParty", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Loan to a third party", "documentation": "Loan to third party." } } }, "auth_ref": [] }, "ifrs-full_LoansReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LoansReceived", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Principal amount" } }, "en": { "role": { "documentation": "The amount of loans received." } } }, "auth_ref": [ "r393" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "GDTC_LongevityBankPteLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LongevityBankPteLtdMember", "presentation": [ "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "LongevityBank Pte Ltd [member]", "documentation": "LongevityBank Pte Ltd [member]" } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "verboseLabel": "Borrowings", "label": "Bank loan, non-current" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r395" ] }, "GDTC_LossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LossAttributableToNoncontrollingInterests", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Loss allocated to NCI", "documentation": "Loss allocated to non-controlling interest." } } }, "auth_ref": [] }, "GDTC_LossBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "LossBeforeIncomeTax", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss before income tax", "documentation": "Loss before income tax" } } }, "auth_ref": [] }, "ifrs-full_LossesOnDisposalsOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "LossesOnDisposalsOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Written off of property, plant and equipment", "label": "Losses on disposals of property, plant and equipment" } }, "en": { "role": { "documentation": "The losses on the disposal of property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r40" ] }, "country_MY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "MY", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "MALAYSIA" } } }, "auth_ref": [] }, "currency_MYR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2024", "localname": "MYR", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Malaysia, Ringgits" } } }, "auth_ref": [] }, "GDTC_MarketReadinessAssistanceGrantMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "MarketReadinessAssistanceGrantMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Market readiness assistance grant [member]", "documentation": "Market readiness assistance grant [member]" } } }, "auth_ref": [] }, "cyd_MaterialCybersecurityIncidentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAbstract", "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Abstract]" } } }, "auth_ref": [ "r322", "r323" ] }, "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]" } } }, "auth_ref": [ "r322", "r324" ] }, "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]" } } }, "auth_ref": [ "r322", "r325" ] }, "cyd_MaterialCybersecurityIncidentNatureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentNatureTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Nature [Text Block]" } } }, "auth_ref": [ "r322", "r325" ] }, "cyd_MaterialCybersecurityIncidentScopeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentScopeTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Scope [Text Block]" } } }, "auth_ref": [ "r322", "r325" ] }, "cyd_MaterialCybersecurityIncidentTimingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTimingTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Timing [Text Block]" } } }, "auth_ref": [ "r322", "r325" ] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r20", "r166", "r173", "r175", "r178", "r179", "r180", "r181", "r190", "r198", "r239", "r271" ] }, "ifrs-full_MaturityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "MaturityDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails", "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r20", "r166", "r173", "r175", "r178", "r179", "r180", "r181", "r190", "r239", "r271", "r273" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r342" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r342" ] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r112", "r116", "r155" ] }, "ifrs-full_MeasurementDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "MeasurementDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalBasedOnDebt-to-equityRatioDetails", "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r112", "r116", "r155" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r362" ] }, "GDTC_MonthlyInstallments": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "MonthlyInstallments", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/BorrowingsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Installments", "documentation": "Monthly installments." } } }, "auth_ref": [] }, "GDTC_MotorVehicleMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "MotorVehicleMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Motor vehicle [member]", "documentation": "Motor vehicle [member]" } } }, "auth_ref": [] }, "ifrs-full_MotorVehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "MotorVehiclesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Motor vehicles [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r236" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_NameOfAssociate": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NameOfAssociate", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Name of entity", "label": "Name of associate" } }, "en": { "role": { "documentation": "The name of an associate. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r83", "r87", "r140" ] }, "ifrs-full_NameOfSubsidiary": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NameOfSubsidiary", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Name of entity" } }, "en": { "role": { "documentation": "The name of a subsidiary. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r83", "r87", "r136", "r138" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r343" ] }, "GDTC_NegativeCashFlowFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NegativeCashFlowFromOperatingActivities", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Negative cash flow from operating activities", "documentation": "Negative cash flow from operating activities." } } }, "auth_ref": [] }, "GDTC_NegativeWorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NegativeWorkingCapital", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Negative working capital", "documentation": "Negative working capital." } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net (liabilities)/assets", "label": "Adjusted net assets of the associate", "verboseLabel": "Adjusted net assets", "terseLabel": "Net financial assets" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r256", "r393" ] }, "GDTC_NetFinancialAssetsliabilitiesDenominatedRespectiveEntitiesFunctionalCurrencies": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NetFinancialAssetsliabilitiesDenominatedRespectiveEntitiesFunctionalCurrencies", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Add: Net financial assets denominated respective entities\u2019 functional currencies", "documentation": "Net financial assets liabilities denominated respective entities functional currencies." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)" } } }, "auth_ref": [] }, "GDTC_NoParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NoParValuePerShare", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "No par value per share", "documentation": "No par value per share." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r342" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r340" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r339" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r370" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r370" ] }, "GDTC_NonadjustingEventMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NonadjustingEventMember", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nonadjusting Event [Member]" } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r43" ] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodDomain", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r43" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests", "verboseLabel": "Adjusted accumulated NCI" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r16", "r135", "r137" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "verboseLabel": "Non-current assets", "periodEndLabel": "Non-current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r21", "r144", "r257" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "GDTC_NoncurrentAssetsIncludingFairValueOfHospitalLicense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NoncurrentAssetsIncludingFairValueOfHospitalLicense", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "label": "Non-current assets (including fair value of hospital license)", "documentation": "Noncurrent assets including fair value of hospital license." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "label": "Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts" } }, "en": { "role": { "documentation": "The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Classes of financial instruments [domain]; Non-current assets]" } } }, "auth_ref": [ "r223" ] }, "ifrs-full_NoncurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentFinancialAssets", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "At beginning of financial year", "periodEndLabel": "At end of financial year", "label": "Non-current financial assets" } }, "en": { "role": { "documentation": "The amount of non-current financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r191" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 }, "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfConsolidatedStatementOfFinancialPositionsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Non-current" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r169" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "verboseLabel": "Non-current liabilities", "negatedLabel": "Non-current liabilities", "periodEndLabel": "Non-current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r22", "r146", "r257" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentReceivables", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade and other receivables", "label": "Trade and other non-current receivables" } }, "en": { "role": { "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]" } } }, "auth_ref": [ "r12", "r23" ] }, "ifrs-full_NoncurrentReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NoncurrentReceivablesAbstract", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Non-Current" } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFutureMinimumPaymentsUnderNon-cancellableDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r19", "r173", "r175", "r181", "r271", "r274" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "GDTC_NotesAndOtherExplanatoryInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NotesAndOtherExplanatoryInformationTable", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "NotesAndOtherExplanatoryInformationTable [Table]" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NumberOfInstrumentsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of ordinary shares" } }, "en": { "role": { "documentation": "The number of instruments granted in share-based payment arrangement." } } }, "auth_ref": [ "r266", "r267" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/GeneralDetailsNarrative", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r391" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "At beginning of financial year", "periodEndLabel": "At end of financial year", "label": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r26" ] }, "GDTC_NumberOfWarrantsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "NumberOfWarrantsOutstanding", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of financial year, Number of Warrants", "periodEndLabel": "End of financial year, Number of Warrants", "documentation": "Number of warrants outstanding.", "label": "NumberOfWarrantsOutstanding" } } }, "auth_ref": [] }, "GDTC_OfferingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OfferingExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Offering expenses", "documentation": "Offering expenses.", "label": "OfferingExpenses" } } }, "auth_ref": [] }, "GDTC_OfferingExpensesAttributableToIssuanceOfNewShares": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OfferingExpensesAttributableToIssuanceOfNewShares", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Offering expenses", "documentation": "Offering expenses of attributable to the issuance of the new shares." } } }, "auth_ref": [] }, "GDTC_OperatingLeaseCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OperatingLeaseCommitments", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOperatingLeaseCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Low value leases", "documentation": "Operating lease commitments." } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments." } } }, "auth_ref": [ "r399" ] }, "ifrs-full_OtherBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherBorrowings", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Borrowing" } }, "en": { "role": { "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]" } } }, "auth_ref": [ "r393" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive (loss)/income:" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails" ], "lang": { "en-us": { "role": { "label": "Other comprehensive gain allocated to NCI" } }, "en": { "role": { "documentation": "The amount of other comprehensive income attributable to non-controlling interests. [Refer: Non-controlling interests; Other comprehensive income]" } } }, "auth_ref": [ "r400" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other receivables", "label": "Other current receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r233" ] }, "ifrs-full_OtherEmployeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherEmployeeExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Employee benefits expenses (Note 22)" } }, "en": { "role": { "documentation": "The amount of employee expenses that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r403" ] }, "GDTC_OtherExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OtherExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Others", "documentation": "Other expense.", "label": "OtherExpense" } } }, "auth_ref": [] }, "ifrs-full_OtherExpenseByFunction": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherExpenseByFunction", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 10.0 }, "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Other expenses", "totalLabel": "Total", "label": "Other expense, by function" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses." } } }, "auth_ref": [ "r42", "r80", "r230" ] }, "ifrs-full_OtherExpenseByNature": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherExpenseByNature", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Others", "label": "Other expenses, by nature" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r42", "r229" ] }, "ifrs-full_OtherGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherGainsLosses", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 }, "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other (losses)/gains including fair value changes on financial instruments - net", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r389", "r390" ] }, "ifrs-full_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Others" } }, "en": { "role": { "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r79", "r229", "r230" ] }, "GDTC_OtherKeyManagementPersonnelMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OtherKeyManagementPersonnelMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Other key management personnel [member]", "documentation": "Other key management personnel [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other operating income", "verboseLabel": "Total" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r400" ] }, "ifrs-full_OtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherPayables", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Other payables" } }, "en": { "role": { "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r395" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r342" ] }, "GDTC_OtherProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OtherProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Professional fees", "documentation": "Other Professional fees.", "label": "OtherProfessionalFeesExpense" } } }, "auth_ref": [] }, "ifrs-full_OtherPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment, acquisition" } }, "en": { "role": { "documentation": "The amount of property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r402" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables", "verboseLabel": "Trade and other receivables" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r233" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r290" ] }, "ifrs-full_OtherReserves": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherReserves", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "verboseLabel": "Translation reserve", "label": "Other reserves" } }, "en": { "role": { "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]" } } }, "auth_ref": [ "r234" ] }, "GDTC_OtherShortTermBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OtherShortTermBenefitsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Other short term benefits [member]", "documentation": "Other short term benefits [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails": { "parentTag": "ifrs-full_ShorttermEmployeeBenefitsExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Other short-term benefits" } }, "en": { "role": { "documentation": "The amount of expense from employee benefits (other than termination benefits), which are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services, that the entity does not separately disclose in the same statement or note. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r404" ] }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "- timing differences arising from revenue recognition" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Unrecorded approximate deferred tax benefits percentage" } }, "en": { "role": { "documentation": "Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r47" ] }, "GDTC_OthersMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OthersMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Others [member]", "documentation": "Others [member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r306", "r317", "r331", "r357" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r309", "r320", "r334", "r360" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r309", "r320", "r334", "r360" ] }, "GDTC_OverprovisionInRespectOfPriorYearsUnabsorbedCapitalAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OverprovisionInRespectOfPriorYearsUnabsorbedCapitalAllowance", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "(Over)/Under-provision in respect of prior years", "documentation": "Overprovision in respect of prior years unabsorbed capital allowance.", "label": "OverprovisionInRespectOfPriorYearsUnabsorbedCapitalAllowance" } } }, "auth_ref": [] }, "GDTC_OverprovisionInRespectOfPriorYearsUnutilizedTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OverprovisionInRespectOfPriorYearsUnutilizedTaxLosses", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "label": "(Over)/Under-provision in respect of prior years", "documentation": "Overprovision in respect of prior years unutilized tax losses." } } }, "auth_ref": [] }, "GDTC_OvertimeMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "OvertimeMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Overtime [member]", "documentation": "Overtime [member]" } } }, "auth_ref": [] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Par value per share", "verboseLabel": "Ordinary shares par value" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r25" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r338" ] }, "ifrs-full_PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Sales and services tax payable" } }, "en": { "role": { "documentation": "The amount of payment due on social security and taxes other than income tax. Income taxes include all domestic and foreign taxes that are based on taxable profits. Income taxes also include taxes, such as withholding taxes, that are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity." } } }, "auth_ref": [ "r398" ] }, "GDTC_PaymentOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "PaymentOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment made", "documentation": "Payment of lease liabilities classified as financing activities.", "label": "PaymentOfLeaseLiabilitiesClassifiedAsFinancingActivities" } } }, "auth_ref": [] }, "GDTC_PaymentToFairValueThroughOtherComprehensiveIncomeInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "PaymentToFairValueThroughOtherComprehensiveIncomeInvestment", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value through other comprehensive income investment", "documentation": "Payment to fair value through other comprehensive income investment.", "label": "PaymentToFairValueThroughOtherComprehensiveIncomeInvestment" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payment of lease liabilities", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r250" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r341" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r341" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r340" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r343" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r339" ] }, "GDTC_PercentageOfDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "PercentageOfDiscountRate", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Percentage of discount rate." } } }, "auth_ref": [] }, "ifrs-full_PercentageOfEntitysRevenue": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PercentageOfEntitysRevenue", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "label": "Revenue growth rate" } }, "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r415" ] }, "ifrs-full_PerformanceObligationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PerformanceObligationsAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Performance obligations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_PerformanceObligationsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PerformanceObligationsDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all performance obligations. A performance obligation is a promise in a contract with a customer to transfer to the customer either: (a) a good or service (or a bundle of goods or services) that is distinct; or (b) a series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer. This member also represents the standard value for the 'Performance obligations' axis if no other member is used." } } }, "auth_ref": [ "r164" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r340" ] }, "ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash consideration" } }, "en": { "role": { "documentation": "The portion of consideration paid or received, consisting of cash and cash equivalents, in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents; Consideration paid (received)]" } } }, "auth_ref": [ "r124" ] }, "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PostemploymentBenefitExpenseDefinedContributionPlans", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails": { "parentTag": "ifrs-full_ShorttermEmployeeBenefitsExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Defined contribution plans" } }, "en": { "role": { "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods." } } }, "auth_ref": [ "r65" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r284" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r286" ] }, "ifrs-full_PrincipalPlaceOfBusinessOfAssociate": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PrincipalPlaceOfBusinessOfAssociate", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal activities", "label": "Principal place of business of associate" } }, "en": { "role": { "documentation": "The principal place of business of an associate. [Refer: Principal place of business; Total for all associates [member]]" } } }, "auth_ref": [ "r84", "r88", "r141" ] }, "GDTC_PrintingAndStationeryExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "PrintingAndStationeryExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Printing and stationery", "documentation": "Printing and stationery expense." } } }, "auth_ref": [] }, "GDTC_PrivateBloodBankingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "PrivateBloodBankingExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Lab consumables and cord-blood banking expenses", "negatedTerseLabel": "Private blood banking expenses", "documentation": "Private blood banking expenses.", "label": "PrivateBloodBankingExpenses" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r248" ] }, "GDTC_ProceedsFromCashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ProceedsFromCashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loan to a third party - net", "documentation": "Proceeds from cash receipts from repayment of advances and loans made to related parties." } } }, "auth_ref": [] }, "GDTC_ProceedsFromDilutionOfInterestInSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ProceedsFromDilutionOfInterestInSubsidiary", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from dilution of interest in a subsidiary", "documentation": "Proceeds from dilution of interest in subsidiary." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of ordinary shares", "verboseLabel": "Aggregate gross proceeds" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_ProceedsFromSalesOfInterestsInAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProceedsFromSalesOfInterestsInAssociates", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceed from disposal of associate" } }, "en": { "role": { "documentation": "The cash inflow from sales of interests in associates. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r408" ] }, "ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of equity investment" } }, "en": { "role": { "documentation": "The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } } }, "auth_ref": [ "r408" ] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r221", "r260" ] }, "ifrs-full_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProductsAndServicesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r221", "r260" ] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Professional fees" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss for the year", "label": "Total", "verboseLabel": "Loss after tax", "terseLabel": "Profit for the year" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r2", "r29", "r119", "r132", "r134", "r214", "r216", "r257", "r263" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss attributable to:" } } }, "auth_ref": [] }, "GDTC_ProfitLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ProfitLossAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-controlling interests", "documentation": "Profit loss on non-controlling interests.", "label": "ProfitLossAttributableToNoncontrollingInterest" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Equity holders of the Company" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r31" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax", "label": "Loss before tax", "verboseLabel": "Loss before income tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r188", "r229", "r230", "r275", "r276" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment", "periodStartLabel": "Property, plant and equipment, beginning", "periodEndLabel": "Property, plant and equipment, ending" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r10", "r58" ] }, "ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentByOperatingLeaseStatusAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment by operating lease status [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r174" ] }, "ifrs-full_PropertyPlantAndEquipmentByOperatingLeaseStatusDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentByOperatingLeaseStatusDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all property, plant and equipment when disaggregated by the operating lease status by a lessor. It also represents the standard value for the 'Property, plant and equipment by operating lease status' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r174" ] }, "ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentPledgedAsSecurity", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Carrying amount of property pledged for bank borrowings" } }, "en": { "role": { "documentation": "The amount of property, plant and equipment pledged as security for liabilities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r60" ] }, "ifrs-full_PropertyPlantAndEquipmentSubjectToOperatingLeasesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentSubjectToOperatingLeasesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment subject to operating leases [member]" } }, "en": { "role": { "documentation": "This member stands for property, plant and equipment that is subject to operating leases. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r174" ] }, "ifrs-full_PropertyTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PropertyTaxExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Property tax" } }, "en": { "role": { "documentation": "The amount of tax expense levied on property. Property is land or a building - or part of a building - or both." } } }, "auth_ref": [ "r400" ] }, "ifrs-full_ProportionOfOwnershipInterestInAssociate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestInAssociate", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfKeyAssumptionsOfInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Group's effective equity interest held rate", "verboseLabel": "Group's equity interest" } }, "en": { "role": { "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r85", "r89", "r142" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership percentage" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r85", "r89", "r139" ] }, "ifrs-full_ProportionOfVotingPowerHeldInAssociate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ProportionOfVotingPowerHeldInAssociate", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Voting rights percent" } }, "en": { "role": { "documentation": "The proportion of the voting rights in an associate held by the entity. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r85", "r89", "r142" ] }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of intangible assets", "label": "Purchase of intangible assets, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r247" ] }, "ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Purchase consideration for acquisition of equity investment" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } } }, "auth_ref": [ "r408" ] }, "ifrs-full_PurchaseOfInvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PurchaseOfInvestmentProperty", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCapitalCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Purchase of a property in Malaysia" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of investment property. [Refer: Investment property]" } } }, "auth_ref": [ "r408" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, plant and equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r247" ] }, "GDTC_PuricellLabPteLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "PuricellLabPteLtdMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPrincipalActivitiesOfSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Puricell Lab Pte Ltd [member]", "documentation": "Puricell Lab Pte Ltd [member]" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r338" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r338" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative", "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r126", "r159", "r180", "r185", "r258", "r259", "r414" ] }, "ifrs-full_RangeDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RangeDomain", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative", "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r126", "r159", "r180", "r185", "r258", "r259", "r414" ] }, "ifrs-full_RecipesFormulaeModelsDesignsAndPrototypes": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RecipesFormulaeModelsDesignsAndPrototypes", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails": { "parentTag": "ifrs-full_IntangibleAssetsAndGoodwill", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Acquired technical disclosure (Note (e))" } }, "en": { "role": { "documentation": "The amount of intangible assets representing recipes, formulae, models, designs and prototypes. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r244" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r301", "r312", "r326", "r352" ] }, "ifrs-full_RelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RelatedPartiesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Total for all related parties [member]" } }, "en": { "role": { "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Total for all joint ventures [member]; Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r76" ] }, "GDTC_RenovationMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "RenovationMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Renovation [member]", "documentation": "Renovation [member]" } } }, "auth_ref": [] }, "ifrs-full_RentalExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RentalExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Low-value assets rental" } }, "en": { "role": { "documentation": "The amount of expense recognised on rental activities." } } }, "auth_ref": [ "r400" ] }, "ifrs-full_RentalIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RentalIncome", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails", "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Rental income" } }, "en": { "role": { "documentation": "The amount of income recognised from rental activities." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Repair and maintenance" } }, "en": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts." } } }, "auth_ref": [ "r400" ] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payment of bank borrowings", "negatedTerseLabel": "Payments", "label": "Repayments of borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_ReportableSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ReportableSegmentsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Reportable segments [member]" } }, "en": { "role": { "documentation": "This member stands for operating segments for which IFRS 8 requires information to be disclosed. The entity shall report separately information about an operating segment that meets any of the following quantitative thresholds: (a) reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 per cent or more of the combined revenue, internal and external, of all operating segments; (b) the absolute amount of its reported profit or loss is 10 per cent or more of the greater, in absolute amount, of (i) the combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all operating segments that reported a loss; or (c) assets are 10 per cent or more of the combined assets of all operating segments. Additionally operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately disclosed, if management believes that information about the segment would be useful to users of the financial statements. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r163", "r214", "r238", "r265" ] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 5.0 }, "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Research expenses", "totalLabel": "Total", "label": "Research and development expense" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r110" ] }, "GDTC_ResearchIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ResearchIncome", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Research income", "documentation": "Research income." } } }, "auth_ref": [] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Translation reserve" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r69", "r231" ] }, "ifrs-full_ReserveOfSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ReserveOfSharebasedPayments", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShare-basedPaymentReserveDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Share-based payment reserve", "periodStartLabel": "At beginning of financial year", "periodEndLabel": "At end of financial year" } }, "en": { "role": { "documentation": "A component of equity resulting from share-based payments." } } }, "auth_ref": [ "r397" ] }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ReserveOfSharebasedPaymentsMember", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Reserve of share-based payments [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } } }, "auth_ref": [ "r231" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r302", "r313", "r327", "r353" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r303", "r314", "r328", "r354" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r310", "r321", "r335", "r361" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Accumulated losses" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r234", "r235" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r5", "r231" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Revenue" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r34", "r148", "r188", "r209", "r215", "r221", "r222", "r225", "r229", "r230", "r257" ] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDisaggregationOfRevenueFromContractsWithCustomersDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "label": "Revenue from contracts with customers" } }, "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } } }, "auth_ref": [ "r161", "r162" ] }, "ifrs-full_RevenueFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RevenueFromGovernmentGrants", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Government grants" } }, "en": { "role": { "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]" } } }, "auth_ref": [ "r405" ] }, "ifrs-full_RevenueFromInterest": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RevenueFromInterest", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherOperatingIncomeDetails", "http://w2.cytomed.sg/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest income", "label": "Interest income" } }, "en": { "role": { "documentation": "The amount of income arising from interest." } } }, "auth_ref": [ "r150", "r210", "r219", "r393" ] }, "GDTC_ReversalOfGrant": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ReversalOfGrant", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Reversal of grant", "documentation": "Reversal of grant." } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Right of use assets" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r168", "r172" ] }, "ifrs-full_RightofuseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RightofuseAssetsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets [member]" } }, "en": { "role": { "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r167" ] }, "ifrs-full_RoyaltyExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "RoyaltyExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Royalty expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from royalties." } } }, "auth_ref": [ "r400" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r370" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r370" ] }, "country_SG": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "SG", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "SINGAPORE" } } }, "auth_ref": [] }, "currency_SGD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2024", "localname": "SGD", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "Singapore, Dollars" } } }, "auth_ref": [] }, "GDTC_SalariesAndBonusMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "SalariesAndBonusMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Salaries and Bonus [member]", "documentation": "Salaries and Bonus [member]" } } }, "auth_ref": [] }, "ifrs-full_SecuredBankLoansReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SecuredBankLoansReceived", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingOfGroupToInterestRateChangesAndContractualRepaymentDatesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "label": "Secured bank loans received" } }, "en": { "role": { "documentation": "The amount of loans received from banks that have been secured by collateral. [Refer: Loans received]" } } }, "auth_ref": [ "r393" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r278" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r282" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r281" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r287" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "SegmentGeographicalDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails" ], "auth_ref": [] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r96", "r163", "r214", "r238", "r265" ] }, "ifrs-full_SegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SegmentsDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBusinessSegmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r96", "r163", "r220", "r238", "r265" ] }, "ifrs-full_SeparateManagementEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SeparateManagementEntitiesAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Separate management entities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r74" ] }, "ifrs-full_SeparateManagementEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SeparateManagementEntitiesDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for separate entities that provide key management personnel services to the entity. It also represents the standard value for the 'Separate management entities' axis if no other member is used. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r74" ] }, "ifrs-full_ServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ServicesExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Service fees" } }, "en": { "role": { "documentation": "The amount of expense arising from services." } } }, "auth_ref": [ "r400" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "auth_ref": [] }, "GDTC_ShareBasedCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ShareBasedCompensationMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Share based compensation [member]", "documentation": "Share based compensation [member]" } } }, "auth_ref": [] }, "GDTC_ShareIssuedAndCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ShareIssuedAndCapitalized", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShare-basedPaymentReserveDetails" ], "lang": { "en-us": { "role": { "label": "Share issued and capitalized in the year", "documentation": "Share issued and capitalized." } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital", "weight": -1.0, "order": 5.0 }, "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfCashFlows", "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share of results of associate", "negatedLabel": "Share of results of associate" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Profit (loss)]" } } }, "auth_ref": [ "r400" ] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfInvestmentInAssociateDetails" ], "lang": { "en-us": { "role": { "label": "Share of post-acquisition profit/(losses)" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Total for all joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r36", "r212", "r219" ] }, "GDTC_SharesOfferingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "SharesOfferingPercentage", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares offering percent", "documentation": "Shares offering percentage." } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfBorrowingsDetails", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Borrowings", "verboseLabel": "Bank loan, current" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r395" ] }, "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ShorttermDepositsClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "GDTC_CashAndCashEquivalentsBeforeFixedDepositMaturityAdjustment", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term fixed deposits" } }, "en": { "role": { "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r413" ] }, "ifrs-full_ShorttermEmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "ShorttermEmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Short-term employee benefits expense" } }, "en": { "role": { "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SignificantInvestmentsInAssociatesAxis", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en-us": { "role": { "label": "Associates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r86", "r90", "r154" ] }, "ifrs-full_SignificantInvestmentsInAssociatesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "SignificantInvestmentsInAssociatesDomain", "presentation": [ "http://w2.cytomed.sg/role/InvestmentInAssociateDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationInvestmentInAssociateDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationOfFinancialInformationInInvestmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "auth_ref": [ "r86", "r90", "r154" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r285" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementGeographicalAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfGeographicalInformationInNon-currentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://w2.cytomed.sg/role/EventsOccurringAfterBalanceSheetDateDetailsNarrative", "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfFinancialInformationOfNon-controllingInterestsDetails", "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails", "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r305", "r316", "r330", "r356" ] }, "GDTC_StrengthenedMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "StrengthenedMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Strengthened [member]", "documentation": "Strengthened [member]" } } }, "auth_ref": [] }, "GDTC_SubscriptionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "SubscriptionExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Subscription fee", "documentation": "Subscription expense." } } }, "auth_ref": [] }, "GDTC_SundryDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "SundryDeposits", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherReceivables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Sundry deposits", "documentation": "Sundry deposits." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r349" ] }, "GDTC_TaxEffectOfDeferredTaxAssetsNotRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TaxEffectOfDeferredTaxAssetsNotRecognized", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "- deferred tax assets not recognized", "documentation": "Tax effect of deferred tax assets not recognized." } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "- expenses not deductible for tax purposes" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_TaxEffectOfForeignTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TaxEffectOfForeignTaxRates", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "- different tax rates in other countries" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "- income not subject to tax", "label": "Tax effect of revenues exempt from taxation" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Tax calculated at tax rate of 17%" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r46" ] }, "GDTC_TaxLossesForDeferredTaxAssetRecognisedWithNoExpiration": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TaxLossesForDeferredTaxAssetRecognisedWithNoExpiration", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpenseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax losses with no expiry", "documentation": "Tax losses with no expiry." } } }, "auth_ref": [] }, "GDTC_TechnicalMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TechnicalMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Technical [member]", "documentation": "Technical [member]" } } }, "auth_ref": [] }, "ifrs-full_TechnologybasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TechnologybasedIntangibleAssetsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Technology-based intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r407" ] }, "GDTC_ThirdPartyLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ThirdPartyLoanMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "label": "Third party loan [member]", "documentation": "Third party loan [member]" } } }, "auth_ref": [] }, "GDTC_ThirdPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ThirdPartyMember", "presentation": [ "http://w2.cytomed.sg/role/TradeAndOtherReceivablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Third party [member]", "documentation": "Third party [member]" } } }, "auth_ref": [] }, "GDTC_ToolsAndSuppliesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "ToolsAndSuppliesExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Tools and supplies", "documentation": "Tools and supplies." } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://w2.cytomed.sg/role/CashAndBankBalancesDetailsNarrative", "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r126", "r159", "r180", "r185", "r258", "r259", "r414" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r341" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r348" ] }, "GDTC_TotalUndiscountedCashFlowMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TotalUndiscountedCashFlowMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails" ], "lang": { "en-us": { "role": { "label": "Total undiscounted cash flow [member]", "documentation": "Total undiscounted cash flow [member]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Trade and other payables" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Trade and other receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r12", "r23" ] }, "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TradeAndOtherCurrentReceivablesAbstract", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TradeAndOtherPayables", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfRemainingContractualMaturitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "verboseLabel": "Trade and other payables", "negatedLabel": "Trade and other payables", "label": "Trade and other payables [Default Label]" } }, "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TradeAndOtherPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade payable" } }, "en": { "role": { "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business." } } }, "auth_ref": [ "r398" ] }, "ifrs-full_TradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfTradeAndOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Trade and other receivables [Default Label]" } }, "en": { "role": { "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]" } } }, "auth_ref": [ "r12", "r23" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r369" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r371" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnsatisfiedPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "label": "Partially and fully unsatisfied performance obligations" } }, "en": { "role": { "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]" } } }, "auth_ref": [ "r165" ] }, "GDTC_TransactionsWithOwnersOfCompanyRecognizedDirectlyInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TransactionsWithOwnersOfCompanyRecognizedDirectlyInEquityAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Transactions with owners of the Company recognized directly in equity" } } }, "auth_ref": [] }, "ifrs-full_TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Research income", "label": "Transfers of research and development from entity, related party transactions" } }, "en": { "role": { "documentation": "The amount of transfers of research and development from the entity in related party transactions. [Refer: Total for all related parties [member]]" } } }, "auth_ref": [ "r240" ] }, "ifrs-full_TransportationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TransportationExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Transportation and travelling expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from transportation services." } } }, "auth_ref": [ "r393" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r372" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r373" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r373" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r371" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r371" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r372" ] }, "GDTC_TwoThousandAndTwentyThreeEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TwoThousandAndTwentyThreeEquityIncentivePlanMember", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2023 Equity incentive plan [member]", "documentation": "2023 Equity incentive plan [member]" } } }, "auth_ref": [] }, "GDTC_TwoThousandTwentyThreeEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "TwoThousandTwentyThreeEquityIncentivePlanMember", "presentation": [ "http://w2.cytomed.sg/role/Share-basedPaymentReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2023 Equity Incentive Plan [Member]", "documentation": "2023 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r94" ] }, "ifrs-full_TypesOfAntidilutiveInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsDomain", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r94" ] }, "ifrs-full_TypesOfContractsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TypesOfContractsAxis", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of contracts [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r261", "r264" ] }, "ifrs-full_TypesOfContractsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "TypesOfContractsDomain", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } } }, "auth_ref": [ "r261", "r264" ] }, "currency_USD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2024", "localname": "USD", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails" ], "lang": { "en-us": { "role": { "label": "United States of America, Dollars" } } }, "auth_ref": [] }, "GDTC_USDAgainstSGDMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "USDAgainstSGDMember", "presentation": [ "http://w2.cytomed.sg/role/FinancialInstrumentsFinancialRisksAndCapitalRisksManagementDetailsNarrative", "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "USD against SGD [member]", "documentation": "USD against SGD [member]" } } }, "auth_ref": [] }, "GDTC_UnabsorbedCapitalAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnabsorbedCapitalAllowance", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpenseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unabsorbed capital allowance", "documentation": "Unabsorbed capital allowance." } } }, "auth_ref": [] }, "GDTC_UnabsorbedTaxLossesForCapitalAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnabsorbedTaxLossesForCapitalAllowance", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unabsorbed capital allowance, At beginning of year", "periodEndLabel": "Unabsorbed capital allowance, At end of year", "documentation": "Unabsorbed tax losses for capital allowance.", "label": "UnabsorbedTaxLossesForCapitalAllowance" } } }, "auth_ref": [] }, "GDTC_UnderProvisionOfPriorYearTax": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnderProvisionOfPriorYearTax", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfIncomeTaxExpensesDetails" ], "lang": { "en-us": { "role": { "label": "- under provision of prior year tax", "documentation": "Under provision of prior year tax." } } }, "auth_ref": [] }, "GDTC_UnderwritingAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnderwritingAgreementsMember", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriting agreements [member]", "documentation": "Underwriting agreements [member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r368" ] }, "GDTC_UnquotedEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnquotedEquityInstruments", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfCurrencyExposureBasedOnInformationDetails", "http://w2.cytomed.sg/role/ScheduleOfEachClassOfFinancialInstrumentsMeasuredAtFairValueDetails", "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at FVOCI", "verboseLabel": "Unquoted equity instruments", "documentation": "Unquoted equity instruments." } } }, "auth_ref": [] }, "GDTC_UnusedTaxLossesForDeferredTaxAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnusedTaxLossesForDeferredTaxAsset", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/IncomeTaxExpenseDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unused tax losses", "documentation": "Unused tax losses for deferred tax asset." } } }, "auth_ref": [] }, "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unutilized tax losses, At beginning of year", "periodEndLabel": "Unutilized tax losses, At end of year", "label": "Unused tax losses for which no deferred tax asset recognised" } }, "en": { "role": { "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]" } } }, "auth_ref": [ "r48" ] }, "GDTC_UnutilizedTaxLossesAndUnabsorbedCapitalAllowanceNet": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UnutilizedTaxLossesAndUnabsorbedCapitalAllowanceNet", "crdr": "debit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfUnutilizedTaxLossesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total", "documentation": "Unutilized tax losses and unabsorbed capital allowance net", "label": "UnutilizedTaxLossesAndUnabsorbedCapitalAllowanceNet" } } }, "auth_ref": [] }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://w2.cytomed.sg/role/MaterialAccountingPolicyInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible assets, estimated useful lives" } }, "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r101" ] }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfPropertyPlantAndEquipmentEstimatedUsefulLivesDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful lives" } }, "en": { "role": { "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r51" ] }, "ifrs-full_UtilitiesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "UtilitiesExpense", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails": { "parentTag": "ifrs-full_OtherExpenseByFunction", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Utilities", "label": "Utilities expense" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased utilities." } } }, "auth_ref": [ "r393" ] }, "GDTC_UtilitiesResearchExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "UtilitiesResearchExpenses", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfResearchExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Utilities", "documentation": "Utilities research expenses." } } }, "auth_ref": [] }, "ifrs-full_WagesAndSalaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WagesAndSalaries", "crdr": "debit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails": { "parentTag": "ifrs-full_ShorttermEmployeeBenefitsExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfEmployeeBenefitsExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Salaries and bonus" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r404" ] }, "GDTC_WarrantExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WarrantExercised", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Warrant exercised", "documentation": "Warrant exercised." } } }, "auth_ref": [] }, "GDTC_WarrantLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WarrantLiabilitiesMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetails", "http://w2.cytomed.sg/role/ScheduleOfReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities [member]", "documentation": "Warrant liabilities [member]" } } }, "auth_ref": [] }, "ifrs-full_WarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WarrantLiability", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/StatementsOfFinancialPositions": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFinancialInstrumentsDetails", "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfFinancialPositions" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities", "periodStartLabel": "Beginning of financial year, Amount", "periodEndLabel": "End of financial year, Amount", "verboseLabel": "Warrants" } }, "en": { "role": { "documentation": "The amount of warrant liabilities." } } }, "auth_ref": [ "r395" ] }, "ifrs-full_WarrantReserve": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WarrantReserve", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantReserveDetails", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "At beginning of year", "periodEndLabel": "At end of year", "label": "Warrant reserve amount" } }, "en": { "role": { "documentation": "A component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments]" } } }, "auth_ref": [ "r397" ] }, "GDTC_WarrantReserveCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WarrantReserveCapitalised", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Warrant reserve capitalized in the year", "documentation": "Warrant reserve capitalised." } } }, "auth_ref": [] }, "ifrs-full_WarrantReserveMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WarrantReserveMember", "presentation": [ "http://w2.cytomed.sg/role/ReconciliationsOfLiabilitiesArisingFromFinancingActivitiesDetailsNarrative", "http://w2.cytomed.sg/role/StatementsOfChangesInEquity", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant reserve [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]" } } }, "auth_ref": [ "r392" ] }, "GDTC_WarrantsExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WarrantsExpirationPeriod", "presentation": [ "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expire period", "documentation": "Warrants expiration period." } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfFairValueOfWarrantsDetails", "http://w2.cytomed.sg/role/ShareCapitalDetailsNarrative", "http://w2.cytomed.sg/role/WarrantLiabilitiesAndWarrantReserveDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for warrants." } } }, "auth_ref": [ "r406" ] }, "GDTC_WeakenedMember": { "xbrltype": "domainItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WeakenedMember", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfNetFinancialLiabilityAssetCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "weakened [member]", "documentation": "weakened [member]" } } }, "auth_ref": [] }, "GDTC_WeightedAverageExercisePriceOfShareOptionsExercisableInCurrencyRealignment": { "xbrltype": "perShareItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInCurrencyRealignment", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Currency realignment, Weighted Average Exercise Price", "documentation": "Weighted average exercise price of share options exercisable in currency realignment." } } }, "auth_ref": [] }, "GDTC_WeightedAverageExercisePriceOfShareOptionsExercisableInFairValueChangesToProfitOrLoss": { "xbrltype": "perShareItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInFairValueChangesToProfitOrLoss", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair value changes to profit or loss, Weighted Average Exercise Price", "documentation": "Weighted average exercise price of share options exercisable in fair value changes to profit or loss." } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfWarrantLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of financial year, Weighted Average Exercise Price", "periodEndLabel": "End of financial year, Weighted Average Exercise Price", "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r184" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic", "label": "Weighted average number of ordinary shares used in calculating basic earnings per share" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r93" ] }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full", "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "presentation": [ "http://w2.cytomed.sg/role/StatementsOfProfitOrLossAndOtherComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in computing loss per share" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://w2.cytomed.sg/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r386" ] }, "GDTC_WrittenOffOfIntangibleAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WrittenOffOfIntangibleAsset", "crdr": "credit", "calculation": { "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails": { "parentTag": "ifrs-full_OtherGainsLosses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfOtherLossesgains-NetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Written off of intangible asset", "documentation": "Written off of intangible asset.", "label": "WrittenOffOfIntangibleAsset" } } }, "auth_ref": [] }, "GDTC_WrittenOffOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://w2.cytomed.sg/20251231", "localname": "WrittenOffOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "credit", "presentation": [ "http://w2.cytomed.sg/role/ScheduleOfDetailedInformationAboutIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Written off", "negatedLabel": "Written off", "documentation": "The amount of written off to investment property other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Investment property]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_104&doctype=Standard", "URIDate": "2024-03-27" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2024-03-27" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2024-03-27" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2024-03-27" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2024-03-27" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106&doctype=Standard", "URIDate": "2024-03-27" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2024-03-27" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "138", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_138_b&doctype=Standard", "URIDate": "2024-03-27" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_35&doctype=Standard", "URIDate": "2024-03-27" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_51&doctype=Standard", "URIDate": "2024-03-27" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2024-03-27" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2024-03-27" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2024-03-27" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2024-03-27" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2024-03-27" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2024-03-27" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2024-03-27" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2024-03-27" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard", "URIDate": "2024-03-27" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2024-03-27" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_61&doctype=Standard", "URIDate": "2024-03-27" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard", "URIDate": "2024-03-27" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_69&doctype=Standard", "URIDate": "2024-03-27" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2024-03-27" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2024-03-27" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2024-03-27" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2024-03-27" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2024-03-27" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard", "URIDate": "2024-03-27" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2024-03-27" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2024-03-27" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2024-03-27" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2024-03-27" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2024-03-27" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_c&doctype=Standard", "URIDate": "2024-03-27" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2024-03-27" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2024-03-27" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "98", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_a&doctype=Standard", "URIDate": "2024-03-27" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "98", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_c&doctype=Standard", "URIDate": "2024-03-27" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "98", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_98_d&doctype=Standard", "URIDate": "2024-03-27" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard", "URIDate": "2024-03-27" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2024-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&anchor=para_21&doctype=Standard", "URIDate": "2024-03-27" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2024-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2024-03-27" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard", "URIDate": "2024-03-27" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2024-03-27" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "81", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2024-03-27" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2024-03-27" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2024-03-27" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2024-03-27" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2024-03-27" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_v&doctype=Standard", "URIDate": "2024-03-27" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2024-03-27" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2024-03-27" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2024-03-27" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_73&doctype=Standard", "URIDate": "2024-03-27" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "74", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_74_a&doctype=Standard", "URIDate": "2024-03-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2024-03-27" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2024-03-27" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138&doctype=Standard", "URIDate": "2024-03-27" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_142&doctype=Standard", "URIDate": "2024-03-27" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard", "URIDate": "2024-03-27" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2024-03-27" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2024-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2024-03-27" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2024-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2024-03-27" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2024-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2024-03-27" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2024-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_53&doctype=Standard", "URIDate": "2024-03-27" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2024-01-01", "Paragraph": "57", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2024-03-27" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2024-03-27" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18&doctype=Standard", "URIDate": "2024-03-27" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "18A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18A&doctype=Standard", "URIDate": "2024-03-27" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "19", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19_d&doctype=Standard", "URIDate": "2024-03-27" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_19&doctype=Standard", "URIDate": "2024-03-27" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard", "URIDate": "2024-03-27" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2024-03-27" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2024-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_iv&doctype=Standard", "URIDate": "2024-03-27" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2024-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_vii&doctype=Standard", "URIDate": "2024-03-27" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2024-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2024-03-27" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard", "URIDate": "2024-03-27" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_i&doctype=Standard", "URIDate": "2024-03-27" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2024-03-27" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2024-03-27" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_i&doctype=Standard", "URIDate": "2024-03-27" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2024-03-27" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2024-03-27" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2024-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard", "URIDate": "2024-03-27" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2024-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_67&doctype=Standard", "URIDate": "2024-03-27" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2024-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2024-03-27" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2024-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2024-03-27" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2024-01-01", "Paragraph": "130", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2024-03-27" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2024-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2024-01-01", "Paragraph": "130", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_130_f_i&doctype=Standard", "URIDate": "2024-03-27" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2024-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2024-03-27" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2024-01-01", "Paragraph": "134", "Subparagraph": "e", "Clause": "iiA", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_134_e_iiA&doctype=Standard", "URIDate": "2024-03-27" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2024-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2024-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2024-03-27" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2024-03-27" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2024-03-27" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2024-03-27" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2024-03-27" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2024-03-27" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2024-03-27" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2024-03-27" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_118&doctype=Standard", "URIDate": "2024-03-27" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "122", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_122_b&doctype=Standard", "URIDate": "2024-03-27" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard", "URIDate": "2024-03-27" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2024-03-27" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2024-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2024-03-27" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2024-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_76&doctype=Standard", "URIDate": "2024-03-27" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2024-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2024-03-27" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2024-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2024-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2024-03-27" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2024-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard", "URIDate": "2024-03-27" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2024-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2024-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2024-03-27" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard", "URIDate": "2024-03-27" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2024-03-27" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard", "URIDate": "2024-03-27" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard", "URIDate": "2024-03-27" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard", "URIDate": "2024-03-27" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35&doctype=Standard", "URIDate": "2024-03-27" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "40", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_b&doctype=Standard", "URIDate": "2024-03-27" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "44B", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44B_d&doctype=Standard", "URIDate": "2024-03-27" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "44H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44H_b_iii&doctype=Standard", "URIDate": "2024-03-27" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard", "URIDate": "2024-03-27" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "46", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_46&doctype=Standard", "URIDate": "2024-03-27" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2024-03-27" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI", "URIDate": "2024-03-27" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2024-03-27" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2024-03-27" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2024-03-27" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2024-03-27" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2024-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2024-en-r&anchor=para_22&doctype=Standard", "URIDate": "2024-03-27" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_a&doctype=Standard", "URIDate": "2024-03-27" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2024-03-27" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "19B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_a&doctype=Standard", "URIDate": "2024-03-27" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2024-03-27" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "21", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_21_a_i&doctype=Standard", "URIDate": "2024-03-27" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "21", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_21_a_iii&doctype=Standard", "URIDate": "2024-03-27" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "21", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_21_a_iv&doctype=Standard", "URIDate": "2024-03-27" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B13", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B13", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2024-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2024-03-27" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2024-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2024-03-27" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2024-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2024-03-27" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2024-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93&doctype=Standard", "URIDate": "2024-03-27" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2024-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2024-03-27" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_105&doctype=Standard", "URIDate": "2024-03-27" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2024-03-27" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_114&doctype=Standard", "URIDate": "2024-03-27" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_115&doctype=Standard", "URIDate": "2024-03-27" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_119&doctype=Standard", "URIDate": "2024-03-27" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "120", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_a&doctype=Standard", "URIDate": "2024-03-27" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2024-03-27" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard", "URIDate": "2024-03-27" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2024-03-27" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2024-03-27" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2024-03-27" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "53", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2024-03-27" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2024-03-27" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_94&doctype=Standard", "URIDate": "2024-03-27" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "95", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_95&doctype=Standard", "URIDate": "2024-03-27" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&anchor=para_97&doctype=Standard", "URIDate": "2024-03-27" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2024-03-27" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2024-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2024-03-27" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109&doctype=Standard", "URIDate": "2024-03-27" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2024-03-27" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_120&doctype=Standard", "URIDate": "2024-03-27" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2024-03-27" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2024-03-27" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2024-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_44&doctype=Standard", "URIDate": "2024-03-27" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2024-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2024-03-27" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2024-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2024-03-27" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2024-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2024-03-27" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2024-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2024-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2024-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2024-03-27" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2024-03-27" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2024-03-27" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard", "URIDate": "2024-03-27" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_31&doctype=Standard", "URIDate": "2024-03-27" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2024-03-27" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2024-03-27" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2024-03-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2024-03-27" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_36&doctype=Standard", "URIDate": "2024-03-27" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2024-03-27" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2024-03-27" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_6&doctype=Standard", "URIDate": "2024-03-27" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard", "URIDate": "2024-03-27" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "8", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_e&doctype=Standard", "URIDate": "2024-03-27" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "8", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_f&doctype=Standard", "URIDate": "2024-03-27" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "8", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_g&doctype=Standard", "URIDate": "2024-03-27" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "8", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8&doctype=Standard", "URIDate": "2024-03-27" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "B2", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2024-03-27" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2024-03-27" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_c&doctype=Standard", "URIDate": "2024-03-27" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2024-03-27" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2024-03-27" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2024-03-27" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard", "URIDate": "2024-03-27" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2024-03-27" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2024-03-27" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2024-03-27" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2024-03-27" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2024-03-27" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28&doctype=Standard", "URIDate": "2024-03-27" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard", "URIDate": "2024-03-27" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2024-03-27" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2024-03-27" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard", "URIDate": "2024-03-27" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard", "URIDate": "2024-03-27" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2024-03-27" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2024-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2024-03-27" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2024-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2024-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2024-03-27" }, "r229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard", "URIDate": "2024-03-27" }, "r230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard", "URIDate": "2024-03-27" }, "r231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard", "URIDate": "2024-03-27" }, "r232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_68&doctype=Standard", "URIDate": "2024-03-27" }, "r233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2024-03-27" }, "r234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2024-03-27" }, "r235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2024-03-27" }, "r236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "37", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_f&doctype=Standard", "URIDate": "2024-03-27" }, "r237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2024-03-27" }, "r238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2024-03-27" }, "r239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2024-03-27" }, "r240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "24", "IssueDate": "2024-01-01", "Paragraph": "21", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_21_e&doctype=Standard", "URIDate": "2024-03-27" }, "r241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2024-03-27" }, "r242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "119", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_d&doctype=Standard", "URIDate": "2024-03-27" }, "r243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "119", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_e&doctype=Standard", "URIDate": "2024-03-27" }, "r244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "119", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_f&doctype=Standard", "URIDate": "2024-03-27" }, "r245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "119", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119_g&doctype=Standard", "URIDate": "2024-03-27" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "14", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_14_f&doctype=Standard", "URIDate": "2024-03-27" }, "r247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2024-03-27" }, "r248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2024-03-27" }, "r249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2024-03-27" }, "r250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2024-03-27" }, "r251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard", "URIDate": "2024-03-27" }, "r252": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2024-03-27" }, "r253": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "44D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_44D&doctype=Standard", "URIDate": "2024-03-27" }, "r254": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI", "URIDate": "2024-03-27" }, "r255": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2024-03-27" }, "r256": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2024-03-27" }, "r257": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r258": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2024-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r259": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2024-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2024-03-27" }, "r260": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r261": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "B89", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r262": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2024-01-01", "Paragraph": "B89", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2024-en-r&anchor=para_B89_e&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r263": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2024-03-27" }, "r264": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "96", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2024-03-27" }, "r265": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2024-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2024-03-27" }, "r266": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2024-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2024-03-27" }, "r267": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2024-01-01", "Paragraph": "IG23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_IG23&doctype=Implementation%20Guidance", "URIDate": "2024-03-27" }, "r268": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35I", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I_b&doctype=Standard", "URIDate": "2024-03-27" }, "r269": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2024-03-27" }, "r270": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "B11", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r271": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r272": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r273": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2024-03-27" }, "r274": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2024-03-27" }, "r275": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard", "URIDate": "2024-03-27" }, "r276": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2024-03-27" }, "r277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r278": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r279": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r281": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r283": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r284": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r285": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r286": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r287": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r288": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r289": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r290": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r291": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r292": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r293": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r294": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r295": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r296": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r297": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r298": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r299": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r300": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r301": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r302": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r303": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r304": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r305": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r306": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r307": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r308": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r309": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r310": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r311": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r312": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r313": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r314": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r315": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r316": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r317": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r318": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r319": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r320": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r321": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r322": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 6-K", "Section": "General Instruction", "Subsection": "B" }, "r323": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05" }, "r324": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "Instruction", "Paragraph": "2" }, "r325": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "a" }, "r326": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r327": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r328": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r329": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r330": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r331": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r332": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r333": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r334": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r335": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r336": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r338": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r339": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r340": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r341": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r342": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r343": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r344": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r345": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r346": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r347": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r348": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r349": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r350": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r351": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r352": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r353": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r354": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r355": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r356": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r357": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r358": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r359": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r360": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r361": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r362": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r363": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r364": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r365": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r366": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r367": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r368": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r369": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r370": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r371": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r372": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r373": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r374": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r375": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r376": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r377": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r378": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r379": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r380": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r381": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r382": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r383": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r384": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r385": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r386": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r387": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2024-03-27" }, "r389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard", "URIDate": "2024-03-27" }, "r390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard", "URIDate": "2024-03-27" }, "r391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2024-03-27" }, "r392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_108&doctype=Standard", "URIDate": "2024-03-27" }, "r393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2024-03-27" }, "r394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_117&doctype=Standard", "URIDate": "2024-03-27" }, "r395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard", "URIDate": "2024-03-27" }, "r396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2024-03-27" }, "r397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2024-03-27" }, "r398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78&doctype=Standard", "URIDate": "2024-03-27" }, "r399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2024-03-27" }, "r400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2024-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard", "URIDate": "2024-03-27" }, "r401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2024-01-01", "Paragraph": "81", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81&doctype=Standard", "URIDate": "2024-03-27" }, "r402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2024-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2024-en-r&anchor=para_37&doctype=Standard", "URIDate": "2024-03-27" }, "r403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "5", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_5&doctype=Standard", "URIDate": "2024-03-27" }, "r404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2024-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2024-en-r&anchor=para_9&doctype=Standard", "URIDate": "2024-03-27" }, "r405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "20", "IssueDate": "2024-01-01", "Paragraph": "39", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2024-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2024-03-27" }, "r406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2024-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2024-03-27" }, "r407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2024-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_119&doctype=Standard", "URIDate": "2024-03-27" }, "r408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_16&doctype=Standard", "URIDate": "2024-03-27" }, "r409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard", "URIDate": "2024-03-27" }, "r410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2024-03-27" }, "r411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2024-03-27" }, "r412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_20&doctype=Standard", "URIDate": "2024-03-27" }, "r413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard", "URIDate": "2024-03-27" }, "r414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2024-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_7&doctype=Standard", "URIDate": "2024-03-27" }, "r415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "8", "IssueDate": "2024-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard", "URIDate": "2024-03-27" } } }